Benchmark,a idrdw <> extreme,a idrdw <> area,a idrsw <> extreme,a idrsw <> area,is ks < extreme,is ks < area
1.AIGNER_ZEB1_TARGETS,0.9895104895104895,0.9977678571428571,0.9895186335403726,0.99776885319054,0.9953071672354948,0.9973878972572922
1.SANSOM_APC_TARGETS_UP,0.8624708624708625,0.9022321428571428,0.859860248447205,0.9013833110218652,0.8562286689419796,0.8976926425772747
1.BCAT_GDS748_UP,0.921911421911422,0.9544642857142858,0.921972049689441,0.9540383757251227,0.9129692832764505,0.9542882020026121
1.BCAT.100_UP.V1_UP,0.9712509712509713,0.9674107142857142,0.9712732919254659,0.9678714859437751,0.9560580204778157,0.9625598606878537
1.PID_WNT_SIGNALING_PATHWAY,0.47086247086247085,0.18169642857142856,0.47282608695652173,0.18429272646140116,0.3937713310580205,0.2107096212451023
1.LIU_CDX2_TARGETS_UP,0.9529914529914529,0.9700892857142858,0.953027950310559,0.9701026327532352,0.9389931740614335,0.9703961689159774
1.LUCAS_HNF4A_TARGETS_UP,0.9588189588189588,0.9683035714285714,0.9584627329192547,0.9687639446675591,0.9573378839590444,0.9643012625163256
10.LANG_MYB_FAMILY_TARGETS,0.5076186329995647,0.6639004149377593,0.5091383812010444,0.6654564315352697,0.5019564002235886,0.6368330464716007
10.PID_CMYB_PATHWAY,0.7331301697866782,0.8034232365145229,0.7315056570931244,0.8018672199170125,0.7177193963107882,0.774526678141136
100.GO_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.7314739743797632,0.8881928625664389,0.7291430422809007,0.8874976285334851,0.7971336293903916,0.8897222785323332
100.REACTOME_M_G1_TRANSITION,0.7956867196367764,0.9155277145026576,0.7949133322533614,0.9140580535002846,0.8399273314493338,0.9191161564970606
100.REACTOME_MITOTIC_M_M_G1_PHASES,0.8884384627857954,0.9458997722095672,0.884820994654139,0.9430848036425725,0.8897860314897053,0.9444557064666531
100.KEGG_DNA_REPLICATION,0.9151937733095509,0.9614654517843584,0.9152762028187267,0.9616771011193322,0.9319741622930965,0.9612811676464627
100.REACTOME_DNA_REPLICATION,0.8759526512080428,0.9358390280941534,0.8700793779361736,0.9298045911591728,0.8807024626564393,0.9341171700790594
100.EGUCHI_CELL_CYCLE_RB1_TARGETS,0.9983784660288633,0.9994305239179955,0.9983800421189049,0.9992411307152343,0.9967702866370609,0.9993918508007298
100.WHITFIELD_CELL_CYCLE_LITERATURE,0.984271120479974,0.9965831435079726,0.9842864085533776,0.996395370897363,0.9866774323778764,0.9965538212041354
101.BIOCARTA_NFKB_PATHWAY,0.8407258064516129,0.908557457212714,0.8407900040306329,0.9090464547677262,0.8663926002055499,0.9164517792676637
101.TIAN_TNF_SIGNALING_VIA_NFKB,0.9665322580645161,0.9789731051344743,0.9665457476823861,0.9789731051344743,0.9825282631038027,0.9747292418772563
101.BIOCARTA_TNFR2_PATHWAY,0.980241935483871,0.993643031784841,0.9802498992341797,0.993643031784841,0.9943473792394656,0.9927797833935018
101.SANA_TNF_SIGNALING_UP,0.8495967741935484,0.9535452322738386,0.8480451430874647,0.9535452322738386,0.8735868448098664,0.9525528623001547
101.PHONG_TNF_TARGETS_UP,0.9641129032258065,0.956479217603912,0.9637243047158404,0.956479217603912,0.9136690647482014,0.9412068076328004
101.SCHOEN_NFKB_SIGNALING,0.9818548387096774,0.9594132029339854,0.9818621523579202,0.9594132029339854,0.9373072970195272,0.9489427539969056
101.GILMORE_CORE_NFKB_PATHWAY,0.9379032258064516,0.945721271393643,0.9375251914550584,0.9452322738386308,0.9573484069886947,0.9448169159360496
102.REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM,0.9952526280094948,0.9962121212121212,0.9952558454761098,0.9962135554714123,0.991628296358309,0.9961750956226094
102.KEGG_BETA_ALANINE_METABOLISM,0.9393014581213971,0.9121212121212121,0.9390037275499831,0.9121544869367664,0.9120971117622436,0.8912027199320017
103.REACTOME_CELL_CYCLE,0.8339878614780436,0.9211861100273118,0.8215560314061384,0.9079563182527302,0.8774809160305344,0.9261213720316622
103.EGUCHI_CELL_CYCLE_RB1_TARGETS,0.976436986790432,0.9921966445571596,0.9764453961456103,0.9921996879875195,0.9904580152671756,0.9928382962683754
103.REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE,0.8961085326669047,0.9484978540772532,0.8940042826552462,0.9477379095163807,0.9251908396946565,0.9528835280814173
104.ESW_FLI_UPREGULATED,0.8413192283758556,0.8981805458362492,0.8403726708074534,0.8985304408677397,0.8598701794578083,0.8780864197530864
105.REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,0.6832638736565037,0.8699186991869918,0.6779846659364732,0.8664695737866469,0.7330655957161981,0.878524374176548
105.MOOTHA_VOXPHOS,0.7280105286246984,0.9132791327913279,0.7263964950711939,0.9122936683912294,0.8310575635876841,0.9201581027667984
105.KEGG_OXIDATIVE_PHOSPHORYLATION,0.7194560210572494,0.8778024143877803,0.7167579408543264,0.8765705838876571,0.7700133868808567,0.8869565217391304
106.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.8374336710082007,0.8581424936386769,0.8348579682233991,0.8536895674300254,0.7126995142262318,0.8404696132596685
106.HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.6931982633863966,0.8326972010178118,0.687048627828599,0.823791348600509,0.6356696738376127,0.8238950276243094
106.HALLMARK_INTERFERON_ALPHA_RESPONSE,0.9556198745779064,0.9446564885496184,0.954260953298026,0.9440203562340967,0.9049271339347675,0.9343922651933702
106.MOSERLE_IFNA_RESPONSE,0.9966232513265798,0.9993638676844784,0.9966297544535387,0.9993638676844784,0.9972241498959056,0.9993093922651933
106.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,0.9889049686444766,0.9561068702290076,0.9884448724121329,0.9561068702290076,0.9673837612768911,0.9330110497237569
106.REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS,0.8437047756874095,0.9128498727735369,0.8435243139142995,0.9115776081424937,0.8861901457321305,0.9060773480662984
106.HECKER_IFNB1_TARGETS,0.8673420164013507,0.8829516539440203,0.8656716417910447,0.8829516539440203,0.7716863289382373,0.8674033149171271
107.GSE7852_LN_VS_FAT_TCONV_DN,0.9885988598859886,0.9642276422764228,0.988622754491018,0.9636127355425601,0.9729377241604173,0.9529295589203424
107.GSE7852_LN_VS_FAT_TREG_DN,0.9945994599459946,0.9980487804878049,0.9946107784431137,0.9980506822612085,0.9983697424193022,0.9980250164581962
107.GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,0.9270927092709271,0.9349593495934959,0.9284431137724551,0.9369720597790773,0.9034887512226932,0.93449637919684
107.GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,0.9957995799579958,0.9977235772357723,0.9958083832335329,0.99772579597141,0.9960873818063254,0.9976958525345622
107.GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.9927992799279928,0.9873170731707317,0.9931137724550898,0.9873294346978557,0.9895663514835344,0.9855167873601053
107.GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.9825982598259826,0.974959349593496,0.9826347305389221,0.9753086419753086,0.9703293120313009,0.9716919025674786
108.CAIRO_HEPATOBLASTOMA_DN,0.8777777777777778,0.8906037221970041,0.8719940806511284,0.8865698729582577,0.8528464017185822,0.8556990454800674
108.HSIAO_LIVER_SPECIFIC_GENES,0.9314814814814815,0.9355424421243759,0.925638179800222,0.9314882032667876,0.9269602577873255,0.9202695115103874
109.WONG_EMBRYONIC_STEM_CELL_CORE,0.7371900826446282,0.8807570977917981,0.7244785949506037,0.8746875,0.6409168081494058,0.8561089825457642
109.BHATTACHARYA_EMBRYONIC_STEM_CELL,0.5710743801652892,0.7088328075709779,0.573271130625686,0.711875,0.3692699490662139,0.6747552149851
11.XU_AKT1_TARGETS_48HR,0.7918115102356122,0.8991825613079019,0.7929039722329349,0.8992283250113482,0.7814258911819888,0.9129226493747105
110.HALLMARK_ALLOGRAFT_REJECTION,0.5433514582303509,0.785245183887916,0.5116072310579868,0.7640829694323145,0.5818406423718344,0.7896678966789668
110.HALLMARK_INTERFERON_ALPHA_RESPONSE,0.9183391003460207,0.9449430823117339,0.9156376568211004,0.9415938864628821,0.8731315626930204,0.9371463714637146
110.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.6761245674740485,0.8498248686514887,0.6635384767361454,0.8334061135371179,0.6609017912291538,0.8472324723247232
110.GO_INTERFERON_GAMMA_MEDIATED_SIGNALING_PATHWAY,0.8151260504201681,0.9197679509632224,0.8122098192235503,0.9170305676855895,0.7735639283508339,0.9202952029520295
110.GO_CELLULAR_RESPONSE_TO_INTERFERON_BETA,0.9114186851211072,0.9539185639229422,0.9114886891237776,0.9537117903930131,0.918591723285979,0.9526445264452644
110.GO_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.817498764211567,0.8547504378283712,0.8163587869208733,0.8541484716157205,0.8127239036442249,0.8469864698646986
111.REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS,0.9730740463724757,0.9851024208566108,0.9730941704035875,0.9851024208566108,0.9810066476733144,0.9887902849135918
111.REACTOME_PYRIMIDINE_METABOLISM,0.8298429319371727,0.8361266294227188,0.8310911808669657,0.8384543761638734,0.8352326685660019,0.8393274170948155
111.KEGG_ONE_CARBON_POOL_BY_FOLATE,0.9087509349289454,0.8784916201117319,0.9091928251121076,0.8798882681564246,0.8979107312440646,0.8664175618869687
112.WONG_MITOCHONDRIA_GENE_MODULE,0.9896275341819897,0.9928872497365648,0.9896324222431668,0.9926238145416227,0.987081620669407,0.9913664781184877
112.MOOTHA_VOXPHOS,0.9988213107024988,0.9986828240252897,0.9988218661639963,0.9986828240252897,0.9985320023487962,0.9967252158380471
112.MOOTHA_HUMAN_MITODB_6_2002,0.9743045733144743,0.9841938883034773,0.9731385485391141,0.981822971548999,0.9706400469759249,0.9776719261685025
112.REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,0.991041961338991,0.9934141201264489,0.9908105560791706,0.9934141201264489,0.9906048150322959,0.9919618934206609
112.STEIN_ESRRA_TARGETS_UP,0.9714757190004715,0.9810326659641728,0.9707822808671065,0.9786617492096944,0.9653552554315913,0.9758856802619827
112.KEGG_RIBOSOME,0.8727015558698727,0.9141201264488936,0.8725259189443921,0.9138566912539515,0.8943041691133294,0.91158082762727
112.REACTOME_TRANSLATION,0.9177274870344178,0.9744467860906217,0.9154099905749293,0.9731296101159115,0.9445096887844979,0.9726108961000298
113.AMIT_DELAYED_EARLY_GENES,0.9956803455723542,0.9989822622855481,0.9956832591393497,0.9989824102340457,0.9993843312297984,0.9988981583503856
113.HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.8642008639308856,0.9216341959872055,0.8602455146364495,0.918156708823957,0.8924118824072649,0.9142137572800252
113.NAGASHIMA_NRG1_SIGNALING_UP,0.8061555075593952,0.912038383250945,0.8030486982328342,0.9094345108300625,0.8585501000461752,0.9101212025814576
113.TIAN_TNF_SIGNALING_NOT_VIA_NFKB,0.9828563714902808,0.9925850537947077,0.9828679347092945,0.9925861317051897,0.9887640449438202,0.9919722965528097
113.RASHI_NFKB1_TARGETS,0.988255939524838,0.9844431520790927,0.9882638607851072,0.9844454135775549,0.9867631214406649,0.9807964741067212
113.DUTTA_APOPTOSIS_VIA_NFKB,0.9542386609071274,0.9890956673451585,0.9541346283555915,0.9890972525076319,0.9722949053409266,0.9894538013536912
113.PHONG_TNF_TARGETS_UP,0.9415496760259179,0.9341378307647572,0.9411844057736409,0.9350196249454863,0.9441280591042019,0.9205099952778215
114.GO_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.9295684261190438,0.9504751461988304,0.929372197309417,0.9494709959868661,0.8796546141392336,0.9512416168207359
114.GO_ALPHA_BETA_T_CELL_ACTIVATION,0.8379592491577089,0.9027777777777778,0.8356822549647662,0.9024078803356439,0.822270192480662,0.9075584556824361
114.GO_IMMUNE_RESPONSE,0.782608695652174,0.9122807017543859,0.6985906470211403,0.8248814301349873,0.8289260658391797,0.9236904114555011
114.GO_CELLULAR_RESPONSE_TO_INTERFERON_GAMMA,0.9444890101074924,0.9672880116959064,0.9420243433696348,0.9644290404961693,0.9338010433531211,0.9682798622439732
114.GO_RESPONSE_TO_TYPE_I_INTERFERON,0.9298892988929889,0.9736842105263158,0.9290518898142216,0.97318496898942,0.944954128440367,0.9775240166757295
114.GO_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.9757741055671426,0.977156432748538,0.9754964766175529,0.9766508573513316,0.947832343946753,0.9760739532354541
114.GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,0.9760949783410877,0.9881213450292398,0.9761370916079436,0.9883254286756659,0.9699586256520957,0.9898495559180714
114.MOSERLE_IFNA_RESPONSE,0.9606930851917215,0.9866593567251462,0.9606021780909674,0.9861364465523531,0.9656413023925167,0.9891245241979336
115.ZHAN_MULTIPLE_MYELOMA_PR_UP,0.96757502587099,0.9927073837739289,0.966930761281433,0.9913400182315406,0.9903437620702974,0.993791230112534
115.EGUCHI_CELL_CYCLE_RB1_TARGETS,0.9751638496033115,0.9986326344576116,0.9751980709610748,0.9981768459434822,0.9953650057937428,0.9988358556461001
115.ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,0.9137633666781649,0.971285323609845,0.9118153634171546,0.9703737465815861,0.966396292004635,0.9751649204501358
115.BENPORATH_PROLIFERATION,0.8409796481545361,0.8719234275296263,0.8370651050637272,0.8678213309024613,0.8814213982232523,0.8855258051998448
116.SINGH_NFE2L2_TARGETS,0.9983876168977749,0.9991922455573505,0.9983922829581994,0.9991938734381298,0.9969801553062986,0.9991364421416234
116.KEGG_PENTOSE_PHOSPHATE_PATHWAY,0.8645598194130926,0.882875605815832,0.8659163987138264,0.8839177750906893,0.685504745470233,0.8769430051813472
117.REACTOME_CHOLESTEROL_BIOSYNTHESIS,0.9925849028622274,0.9979681679647816,0.9925903971547125,0.9979695431472081,0.997602329165953,0.9977785372522214
117.HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.9326709179890257,0.965628174737555,0.9318316538233551,0.9644670050761421,0.9369755095050523,0.9659945317840055
117.KEGG_STEROID_BIOSYNTHESIS,0.9934747145187602,0.9989840839823908,0.993479549496147,0.9989847715736041,0.997944853570817,0.9991455912508544
117.GO_STEROID_BIOSYNTHETIC_PROCESS,0.8387957882248257,0.9371825262444972,0.8372851215174867,0.9348561759729273,0.8802877205000856,0.9362611073137389
118.HORTON_SREBF_TARGETS,0.9153333333333333,0.9817097415506958,0.915,0.9813121272365806,0.9660902000678196,0.9871372031662269
118.REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,0.574,0.7534791252485089,0.573,0.7514910536779325,0.6741268226517464,0.8156332453825857
119.alveolar_KRAS_up,0.8522050059594756,0.9590834697217676,0.8404001905669366,0.9503681483501499,0.9097421203438395,0.9604471195184867
119.JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,0.9485101311084625,0.9328968903436988,0.9485469271081467,0.9329151895282247,0.9467048710601719,0.9271997707079392
12.GLI1_UP.V1_UP,1.0,0.9836065573770492,1.0,0.9836065573770492,1.0,0.9873417721518988
120.GO_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,0.9892378263937897,0.8682835453021789,0.9892387756902179,0.8688750862663907,0.924741105300933,0.8264849471114727
120.GO_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.9147847565278758,0.9552400670413093,0.9148804798447561,0.9552400670413093,0.8637342356198093,0.9556550040683482
120.GO_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.6586097388849682,0.8066646948634526,0.6585516450560113,0.8060731538992408,0.715062032195222,0.8145850284784377
121.PDGF_UP.V1_DN,0.7110947471772214,0.7897071872227152,0.7110294117647059,0.7899556868537666,0.7296692365083313,0.8515473887814313
121.MTOR_UP.N4.V1_UP,0.3649975454099165,0.7246376811594203,0.36004901960784313,0.7140324963072379,0.6127828898284009,0.8109284332688588
121.BMI1_DN_MEL18_DN.V1_UP,0.6102110947471773,0.7734398107068915,0.6071078431372549,0.7716395864106351,0.7060432728177071,0.840183752417795
122.HINATA_NFKB_TARGETS_KERATINOCYTE_UP,0.9468599033816425,0.8657472558401351,0.9462002412545235,0.8649028989586265,0.885179856115108,0.8348436129786612
122.TIAN_TNF_SIGNALING_VIA_NFKB,0.9973429951690821,0.9988741908246552,0.9973462002412545,0.9988741908246552,0.9985611510791367,0.9988307512423268
122.REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,0.5949275362318841,0.6166619757951027,0.5942098914354644,0.615536166619758,0.42503597122302156,0.6068401052323882
122.RASHI_NFKB1_TARGETS,0.9954106280193237,0.9980298339431466,0.995416164053076,0.9980298339431466,0.9945323741007194,0.9985384390529085
122.GILMORE_CORE_NFKB_PATHWAY,0.9888888888888889,0.995778215592457,0.9889022919179734,0.9954967632986209,0.9890647482014389,0.9950306927798889
122.BIOCARTA_NFKB_PATHWAY,0.9922705314009662,0.9814241486068112,0.9922798552472859,0.9814241486068112,0.9553956834532374,0.9801227711195557
122.KAMMINGA_SENESCENCE,0.7794685990338164,0.8544891640866873,0.7794933655006031,0.8550520686743597,0.7939568345323741,0.8588132125109617
123.HALLMARK_TGF_BETA_SIGNALING,0.752963489805595,0.856959753909254,0.7514218009478673,0.8554587391081496,0.8598000465008138,0.8799353498037404
123.BIOCARTA_TGFB_PATHWAY,0.8980559506875296,0.921045885670341,0.8981042654028436,0.9215786776012301,0.893048128342246,0.9240360193950589
123.REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,0.9722617354196301,0.97641630351192,0.9722748815165877,0.9764223475140953,0.9448965356893746,0.976910644193027
123.WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,0.8809862494073021,0.9530889515508844,0.8810426540284361,0.9525884161968221,0.9035108114392002,0.9630570307088432
124.BIOCARTA_IL1R_PATHWAY,0.8670615962800179,0.9374735654870999,0.8665266373878174,0.9370683579985906,0.9003247564326755,0.9306465970704864
124.REACTOME_COMPLEMENT_CASCADE,0.6791515383145423,0.7895812773156633,0.6790783527464833,0.7890063424947146,0.6849029894245983,0.7627255806425508
124.HALLMARK_IL6_JAK_STAT3_SIGNALING,0.7268615835403529,0.8472437614549556,0.7236967729616193,0.8451021846370683,0.7721708718461154,0.8338593509751557
124.GO_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,0.9231161220459901,0.8907373466798252,0.9231748456495449,0.8907681465821,0.9047381130818553,0.8710042890669256
124.ST_JAK_STAT_PATHWAY,0.9557933626345627,0.9760327083039616,0.9557634778180892,0.9760394644115574,0.966441835290199,0.9712713441773894
125.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.9891269587464023,0.9926894959599846,0.9891408495688279,0.9926894959599846,0.9942363112391931,0.9903886335144171
125.REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,0.9661016949152542,0.9680646402462486,0.9661450015969338,0.9680646402462486,0.9757101687937423,0.9644797325532805
126.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.9824911687912763,0.9923357664233576,0.982518018708787,0.9910632865219771,0.9780990856899852,0.9907407407407407
126.REACTOME_INTERFERON_GAMMA_SIGNALING,0.8820457686991245,0.9386861313868613,0.8797730409446404,0.9370782418384096,0.9024027216670211,0.9335016835016835
126.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.6644140684994625,0.70492700729927,0.6663088483361448,0.7065475104869597,0.6049330214756539,0.6893939393939394
127.BCAT_BILD_ET_AL_UP,0.8478558394160584,0.8631198347107438,0.8470132238942089,0.8629677419354839,0.8964132762312634,0.854638619201726
128.CORDENONSI_YAP_CONSERVED_SIGNATURE,0.5317291311754685,0.7447150735294118,0.5328933361720247,0.7458639705882353,0.6512697460507898,0.7898909811694748
128.REACTOME_SIGNALING_BY_HIPPO,0.5851788756388415,0.7681525735294118,0.587183308494784,0.7706801470588235,0.6606678664267147,0.8164519326065411
129.HALLMARK_MYC_TARGETS_V1,0.7789830508474577,0.8361482228384169,0.765861368254685,0.8278379058645859,0.8054519368723099,0.849971477467199
129.HALLMARK_E2F_TARGETS,0.7148022598870056,0.8679102596420469,0.6979002032061413,0.8575383840926252,0.7523672883787661,0.8727895037079293
129.HALLMARK_MYC_TARGETS_V2,0.9380790960451978,0.9740357953113183,0.9367803115827501,0.97382330732444,0.9434720229555237,0.9740444951511694
129.COLLER_MYC_TARGETS_UP,0.8063276836158192,0.9024451726745651,0.8058252427184466,0.9033475962748553,0.8258249641319942,0.9092983456930975
129.SCHUHMACHER_MYC_TARGETS_UP,0.8635028248587571,0.9541215023947568,0.8588846240686385,0.9526805940095645,0.8740315638450502,0.9532230462065031
129.KALMA_E2F1_TARGETS,0.9597740112994351,0.9609276531383917,0.9595845563332581,0.9609866599546942,0.9569583931133429,0.9560752994865944
130.HALLMARK_MTORC1_SIGNALING,0.802719465648855,0.8689359421066738,0.798760133524082,0.8616992763334227,0.8097345132743363,0.8609799291617474
130.HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.8716603053435115,0.8842133476279818,0.8662374821173104,0.8807290270704905,0.8887905604719764,0.8783943329397875
130.HALLMARK_MYC_TARGETS_V1,0.884780534351145,0.9134280353792549,0.8786361468764903,0.9110158134548378,0.8973451327433628,0.9079102715466352
131.KEGG_RIBOSOME,0.6852753840389659,0.845227062094532,0.6851366529389742,0.8457619268179712,0.7261790182868142,0.8573480134035424
131.KEGG_SPLICEOSOME,0.7692019482952417,0.9198331788693235,0.7663796330962186,0.9170912459471978,0.8484119345524542,0.922929631402585
132.KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,0.716572504708098,0.856353591160221,0.7091764705882353,0.8502762430939227,0.7565011820330969,0.8476941747572816
132.BIOCARTA_CYTOKINE_PATHWAY,0.8681732580037664,0.8966850828729281,0.8682352941176471,0.8972375690607735,0.8392434988179669,0.8956310679611651
132.KEGG_CHEMOKINE_SIGNALING_PATHWAY,0.687382297551789,0.7795580110497238,0.6832941176470588,0.7779005524861878,0.7039007092198581,0.7566747572815534
132.HALLMARK_IL6_JAK_STAT3_SIGNALING,0.7391713747645952,0.8364640883977901,0.736,0.8348066298342541,0.7736406619385343,0.8203883495145631
133.Bramswig_Alpha_Strong.genes,0.8429444592080787,0.9576455932731236,0.8292682926829268,0.9520697167755992,0.8986519017814155,0.968705547652916
133.Muraro_ALpha.genes,0.7892638851979803,0.9370912488321396,0.764050901378579,0.9243697478991597,0.8709677419354839,0.9563774300616406
133.Wang_adult_alpha.genes,0.8285942067499336,0.9345998131423232,0.8263520678685048,0.9312169312169312,0.8639865190178142,0.9525841631104789
134.REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT,0.9476950354609929,0.9742429516185173,0.9474305965741288,0.9738948833971458,0.9676067073170732,0.9707016191210486
134.RASHI_RESPONSE_TO_IONIZING_RADIATION_2,0.7612293144208038,0.8545074834667595,0.7590076786769049,0.8520710059171598,0.7938262195121951,0.8319198149575945
135.HALLMARK_MYC_TARGETS_V1,0.9567408651826963,0.9860488290981565,0.9534395973154363,0.9830592924763328,0.9738461538461538,0.9869587897756912
136.GO_MITOTIC_NUCLEAR_DIVISION,0.8809064609450338,0.9468001053463261,0.871868978805395,0.9407426915986304,0.9020576131687242,0.9468599033816425
136.GO_MITOTIC_RECOMBINATION,0.9633558341369335,0.9757703450092178,0.9633911368015414,0.9755069791941006,0.9569272976680384,0.9731615673644659
136.GO_MITOTIC_SPINDLE_ORGANIZATION,0.9549180327868853,0.9586515670265999,0.9542389210019268,0.9578614695812484,0.9508916323731138,0.9551798174986581
136.GO_SISTER_CHROMATID_COHESION,0.9696239151398264,0.99341585462207,0.9679672447013488,0.9923623913616013,0.9843621399176955,0.9943639291465378
136.GO_CELL_CYCLE_PHASE_TRANSITION,0.7970106075216972,0.9180932314985515,0.7887764932562621,0.9104556228601528,0.858161865569273,0.9208266237251744
137.BIOCARTA_PTEN_PATHWAY,0.9387387387387387,0.9018583042973287,0.938770259840494,0.9015965166908563,0.8837066584841976,0.8924302788844621
137.SA_PTEN_PATHWAY,0.941055341055341,0.9024390243902439,0.9410856701826601,0.902177068214804,0.8622276772015955,0.8902850137909899
138.GO_ORGANIC_ACID_METABOLIC_PROCESS,0.6940044114698215,0.8129110840438489,0.6532451923076923,0.7878197320341047,0.7541308658294779,0.8441748588161473
138.GO_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,0.7086424704231,0.8343483556638246,0.6903044871794872,0.822898903775883,0.7891606080634501,0.8665551139928885
138.PID_HNF3B_PATHWAY,0.9498696611189091,0.9028014616321559,0.9499198717948718,0.9030450669914738,0.9090107953293677,0.9073415603430245
139.HALLMARK_E2F_TARGETS,0.9301246738184981,0.979290869155946,0.9263768115942029,0.9786633197364293,0.9542505974735405,0.9803398867044318
139.HALLMARK_MYC_TARGETS_V1,0.7341258335749493,0.8462503922183872,0.7260869565217392,0.8377784750549105,0.7678388528508023,0.842052649116961
139.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.4937663090750942,0.6608095387511767,0.4872463768115942,0.6526513962974584,0.5377261864117446,0.6594468510496501
139.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.9051899101188751,0.9576404141826169,0.9014492753623189,0.954502667085033,0.9337657903721407,0.9576807730756415
14.PID_NFKAPPAB_ATYPICAL_PATHWAY,0.9897367246764837,0.9274499187872225,0.9897413024085637,0.9279913373037358,0.8514538558786346,0.9118404118404119
140.IPA_PAX5_UP,0.9738766980146291,0.9458653026427962,0.973967372440125,0.9460492778249787,0.9088863892013498,0.918429003021148
140.GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,0.6980146290491118,0.7907075873827792,0.6983686220062478,0.7914188615123194,0.6687289088863893,0.7401812688821753
141.REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.9408093416549225,0.9586440677966102,0.9404306701549607,0.9587000677048071,0.9281202352428665,0.95905031583533
141.IPA_SOX10_UP,0.9816790819408093,0.9333333333333333,0.9816864560273697,0.932972241029113,0.938357656284034,0.9146155521672839
142.LUCAS_HNF4A_TARGETS_UP,0.8958887902987281,0.9169410903768752,0.8953900709219859,0.9159356725146199,0.8547557840616966,0.886757136172204
142.IPA_HNF4A_UP,0.9020999704229518,0.9216977680204903,0.901595744680851,0.9210526315789473,0.877892030848329,0.8881609733270941
142.SUMI_HNF4A_TARGETS,0.9692398698609879,0.9769484083424808,0.9692671394799054,0.9758771929824561,0.9610111396743788,0.9639681796911558
142.OHGUCHI_LIVER_HNF4A_TARGETS_DN,0.8775510204081632,0.920234174899378,0.8773640661938534,0.9192251461988304,0.8676092544987146,0.8909686476368741
143.IPA_SPI1_UP,0.9192445457505698,0.9309895833333334,0.9192971038073544,0.9306458604247941,0.8529878371232152,0.9077181208053692
144.IPA_MEIS1_UP,0.9896561364271736,0.9615384615384616,0.9896619167365186,0.9616129032258065,0.9385901162790697,0.9515910629654706
145.ONDER_CDH1_TARGETS_2_DN,0.9802387813915191,0.9904812268640931,0.9790296052631579,0.9889064976228209,0.9786995515695067,0.9861529199277543
145.ONDER_CDH1_TARGETS_3_DN,0.9790037052284891,0.9894235854045479,0.9794407894736842,0.9899630216587427,0.9708520179372198,0.9867549668874173
145.ONDER_CDH1_TARGETS_1_DN,0.6364759160148209,0.5134849286092015,0.6352796052631579,0.5113576333861596,0.43329596412556054,0.4045755568934377
146.GO_MPP7_DLG1_LIN7_COMPLEX,0.999804151978065,0.9569527785024785,0.9998042669798395,0.9569752281616688,0.9547977795400476,0.9391741071428571
147.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.9999050692994115,0.9761068961612501,0.9999051773184146,0.9762282091917591,0.9890572390572391,0.9453323186199899
147.REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,0.99202582115056,0.93466198618503,0.9920348947468235,0.9347973737831107,0.9054834054834054,0.9062658548959919
147.GO_ERBB2_SIGNALING_PATHWAY,0.9019365862920068,0.8602649756539463,0.9020481699222453,0.8601992302467738,0.7997835497835498,0.8144342973110097
147.LANDIS_ERBB2_BREAST_TUMORS_324_UP,0.8838048224795899,0.9002377986637979,0.883652569694671,0.8984604935476568,0.8611111111111112,0.8726534753932014
147.REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,0.9581355610404405,0.7776016306194089,0.958183197420823,0.7781299524564184,0.7449494949494949,0.6903855910705226
148.IPA_FOXA1_UP,0.7804247990815155,0.754877616175949,0.7805507745266781,0.7559334041799504,0.7804681194511703,0.7210335082761405
149.REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,1.0,0.9926233287229138,1.0,0.992626728110599,0.9908829174664108,0.9859665006790402
149.REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,0.9996236356793377,0.9995389580451821,0.9996239187664535,0.9995391705069124,0.9995201535508638,0.9995473064735174
15.PID_IL2_STAT5_PATHWAY,0.9803520261972984,0.9841346153846153,0.9803600654664485,0.984149855907781,0.9802231237322515,0.9785166240409208
15.SCHURINGA_STAT5A_TARGETS_UP,0.9164961113385182,0.7846153846153846,0.9173486088379705,0.7867435158501441,0.8427991886409736,0.732992327365729
15.FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,0.9676627097830536,0.9605769230769231,0.9676759410801964,0.9610951008645533,0.9751521298174443,0.959079283887468
150.REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,0.9799504950495049,0.9477482678983834,0.9799554565701559,0.948066935949221,0.9462695732268959,0.9249917026219715
150.REACTOME_EGFR_DOWNREGULATION,0.9007425742574258,0.8547921478060047,0.9010146003464489,0.8548759376803231,0.8630641694811176,0.8141387321606373
150.REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,0.9975247524752475,0.9942263279445728,0.9972779015095273,0.9942296595499135,0.9966226588885477,0.9880517756388981
150.REACTOME_SIGNALING_BY_EGFR_IN_CANCER,0.8311881188118811,0.5574480369515011,0.8314773570898293,0.5591459896133872,0.6463002763279091,0.4198473282442748
150.REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,0.994059405940594,0.7742494226327945,0.994060876020787,0.7746682054241201,0.802272029474977,0.697311649518752
151.REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,0.9984728938661237,0.9928825622775801,0.9984728938661237,0.9928825622775801,0.9977671451355662,0.9833333333333333
151.REACTOME_MET_PROMOTES_CELL_MOTILITY,0.9559684398065665,0.9264531435349941,0.956222957495546,0.9258600237247924,0.9342902711323764,0.9013605442176871
151.REACTOME_MET_ACTIVATES_PTK2_SIGNALING,0.98345635021634,0.9519572953736655,0.9837108679053195,0.9519572953736655,0.958213716108453,0.9343537414965987
152.REACTOME_DEFECTIVE_GALNT3_CAUSES_FAMILIAL_HYPERPHOSPHATEMIC_TUMORAL_CALCINOSIS_HFTC,0.9821636293136875,0.9945109780439122,0.982170542635659,0.9950099800399201,0.9911553344389166,0.995679012345679
153.IPA_MECOM_UP,0.9587723316536876,0.9761251372118551,0.9588006408789197,0.9761709120788825,0.9391827684510611,0.9719973009446694
154.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.983304423243712,0.9896446222640621,0.9830875975715525,0.9896470588235294,0.9821870361207323,0.9870951417004049
155.REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,0.831041257367387,0.8531237070748863,0.831041257367387,0.8537190082644628,0.7944740668928745,0.827060505002382
156.REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,1.0,0.9987654320987654,1.0,0.9987657368550975,1.0,0.9961538461538462
156.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,0.9993214204931011,0.9555555555555556,0.9993217273343884,0.9558133794124908,0.937682312383983,0.9222527472527473
157.REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.996969696969697,0.9921660791226009,0.996971736204576,0.9921660791226009,0.9983967935871744,0.9844297391981316
158.KOYAMA_SEMA3B_TARGETS_UP,0.40370648635111445,0.49915397631133673,0.4019019019019019,0.4957698815566836,0.4000617856039543,0.42857142857142855
159.SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,0.8724436741767765,0.786616752456715,0.8718836565096952,0.7867165575304023,0.667621776504298,0.7163037080635668
159.SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,0.8467937608318891,0.7908282639213852,0.8469529085872576,0.7904583723105706,0.7186246418338109,0.7168922895821072
159.SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.6783362218370884,0.5952269536733739,0.6772853185595568,0.5944808231992517,0.5484240687679083,0.4714537963507946
159.IPA_IRF4_UP,0.8960138648180243,0.9429106223678053,0.8961218836565097,0.9429373246024322,0.8934097421203439,0.9299587992937022
16.ST_STAT3_PATHWAY,0.9971777986829727,0.9917269906928645,0.9971813341684935,0.9917269906928645,0.992377495462795,0.9877868245743894
16.HALLMARK_IL6_JAK_STAT3_SIGNALING,0.9360301034807149,0.9596690796277145,0.9357970560601315,0.9589796621854533,0.9168784029038113,0.9541080680977054
16.AZARE_STAT3_TARGETS,0.6870492317340859,0.41468459152016546,0.6877544628875666,0.41744226128921064,0.523049001814882,0.31162102146558107
16.DAUER_STAT3_TARGETS_UP,0.9507682659140797,0.9472595656670114,0.9505167554024428,0.94657014822475,0.953901996370236,0.9356032568467801
160.IPA_TP63_UP,0.8709595316874523,0.8769422001243008,0.8707050139984729,0.8760869565217392,0.8313253012048193,0.796557811120918
161.GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,0.4876837093769406,0.30711714206590973,0.48749741682165737,0.3085635359116022,0.3080552746882373,0.07175843694493783
161.IPA_IRF8_UP,0.9018836679776444,0.8296870672943782,0.9022525315147758,0.8303867403314917,0.8153016514998315,0.7548845470692718
161.IPA_IRF8_DN,0.9505278410267025,0.9174743838271947,0.950816284356272,0.9176795580110497,0.8891135827435119,0.8909413854351688
162.IPA_CDX2_DN,0.914569923932124,0.886117136659436,0.9146947122407245,0.8861582941814239,0.8041543026706232,0.8422273781902552
162.LIU_CDX2_TARGETS_UP,0.9362200117027502,0.9251626898047722,0.9363131755769792,0.9255511384170582,0.8448495125052988,0.8979118329466357
162.IPA_CDX2_UP,0.9540667056758338,0.9577006507592191,0.9541338007595677,0.9577159378388146,0.8952946163628657,0.9410672853828306
163.REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,0.6816249409541805,0.8928796471329553,0.680188679245283,0.8935768261964736,0.7222991689750693,0.9052333804809052
164.SINGH_NFE2L2_TARGETS,0.9982939312698026,0.9930408472012103,0.9982955928901874,0.9930450559419414,0.9823550594166367,0.9847094801223242
164.IPA_NFE2L2_UP,0.7007067999025104,0.6732223903177005,0.6990504017531045,0.6706985182945268,0.5070219661505222,0.5691896024464832
165.REACTOME_ACTIVATION_OF_C3_AND_C5,0.9996685449121644,1.0,0.9996688741721854,1.0,0.9986824769433466,1.0
166.REACTOME_CD22_MEDIATED_BCR_REGULATION,0.8994544037412315,0.9822834645669292,0.8999610743479953,0.9818002951303493,0.920932589964521,0.9845281072717896
167.SHI_SPARC_TARGETS_DN,0.9912280701754386,0.1786769720390998,0.9912318220701454,0.17931818181818182,0.14076905779176974,0.1703954802259887
168.REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,0.9947148205241136,0.9753116011505273,0.9947159841479525,0.9753175173735922,0.9813771134525852,0.9658500371195249
169.IPA_FOSL1_UP,0.8996655518394648,0.8028110789582472,0.8996655518394648,0.8032244729226953,0.7699443413729128,0.7562546445380233
17.BIOCARTA_BARRESTIN_SRC_PATHWAY,0.9919753086419754,0.589452603471295,0.9919777846343721,0.5927903871829105,0.48664886515353806,0.5689943200801871
17.BILD_SRC_ONCOGENIC_SIGNATURE,0.4608024691358025,0.16522029372496663,0.4646713977167541,0.16555407209612816,0.26602136181575436,0.1526896090878717
170.IPA_CTNNB1_UP,0.5714007023019898,0.6872141145719887,0.5662180612443924,0.683569096844396,0.5505086349656967,0.657128882367327
170.FEVR_CTNNB1_TARGETS_UP,0.6092469761997659,0.712698758440427,0.5974253949678174,0.7033732317736671,0.5852850721551928,0.677427243824896
171.REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.9992125984251968,0.9808686659772492,0.999213217938631,0.9808686659772492,0.9891041162227603,0.9649614576033637
172.IPA_HNF1A_UP,0.9400256574727389,0.9285432293722858,0.9401024983984625,0.9287120913745569,0.8482527525131642,0.8990731204943357
172.SERVITJA_ISLET_HNF1A_TARGETS_DN,0.9252726106478512,0.9095933675483616,0.9253683536194747,0.909807010634108,0.829583532790809,0.8759011328527292
173.ROZANOV_MMP14_TARGETS_UP,0.7055340469141426,0.8079619429143715,0.703256661352767,0.8055068836045056,0.7010010537407798,0.7893289328932893
173.ROZANOV_MMP14_TARGETS_SUBSET,0.9922568890913231,0.9969954932398598,0.9922568890913231,0.9969962453066333,0.9905163329820864,0.9958745874587459
174.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,1.0,1.0,1.0,1.0,1.0,0.9993686868686869
174.REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,0.9985234403839055,0.7414299706170421,0.9985245296938399,0.7415565345080763,0.7998859749144812,0.5833333333333334
174.REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,0.9937246216315984,0.9157688540646425,0.9937292511988196,0.9158100832109642,0.8819840364880274,0.8983585858585859
174.REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,0.9959394610557402,0.9838393731635652,0.9959424566580598,0.9838472834067548,0.9800456100342075,0.9671717171717171
175.IPA_FOXA2_UP,0.8956901936289818,0.8571428571428571,0.8954431960049938,0.8573529411764705,0.7341818181818182,0.861882437793004
176.REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,0.9979094076655052,0.9959194083142056,0.9979098931723177,0.9959204487506375,0.9902323125659979,0.9936339522546419
177.GO_MPP7_DLG1_LIN7_COMPLEX,0.99546783625731,0.974601593625498,0.9954691610640164,0.9746058091286307,0.931784930504755,0.9636260836788542
178.IPA_KLF5_UP,0.9066603007877775,0.9109112013929194,0.9067270992366412,0.9112786314873876,0.8211716341212744,0.8826003824091778
179.REACTOME_NRCAM_INTERACTIONS,1.0,0.9635007849293563,1.0,0.9635007849293563,0.9349562571319894,0.956268221574344
18.KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,0.7523527830061845,0.8187535734705546,0.7271505376344086,0.7924528301886793,0.7709428129829985,0.7900378310214375
18.REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,0.7230438289862866,-0.1377672209026128,0.7244623655913979,-0.13855898653998416,-0.4921363040629096,-0.4122089364380113
180.IPA_NFIX_UP,0.9853204439670605,0.9793459552495697,0.9853204439670605,0.9793577981651376,0.9515127229012222,0.9801350814461661
181.IPA_POU2F2_UP,0.9596818431157432,0.8772164603546336,0.9597149904083311,0.8773395721925134,0.8693467336683417,0.8316123907863384
182.IPA_ID3_DN,0.8769436997319034,0.6127404604225797,0.8769766818547307,0.6143667296786389,0.5448652337086318,0.5623976416639371
183.MAHAJAN_RESPONSE_TO_IL1A_UP,0.8450517378615017,0.7963746223564955,0.8442557707614752,0.7969788519637462,0.6954500166057788,0.736637168141593
184.REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,0.9561933534743202,0.6759379042690815,0.9561933534743202,0.676147382029735,0.5269645608628659,0.6051779935275081
185.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,0.9817982456140351,0.910837087977235,0.9817982456140351,0.9110742233815509,0.9198748796920115,0.8875029983209403
186.REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,0.9968891402714932,0.9340288432034366,0.9968900197907832,0.9340288432034366,0.8491404860699466,0.9391377852916315
187.BIOCARTA_ERBB3_PATHWAY,1.0,0.9368191721132898,1.0,0.9373368146214099,0.8960489181561618,0.9160530191458026
188.REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,0.9681727131092811,0.9716209716209716,0.9681868743047831,0.9716277951430632,0.9658243080625752,0.9705177372962608
189.GO_CD40_SIGNALING_PATHWAY,0.9949106256206555,0.9102984585109872,0.9949156746031746,0.910327868852459,0.9130179827990618,0.8177381710163378
189.BIOCARTA_CD40_PATHWAY,0.9869662363455809,0.9467038373237127,0.9869791666666666,0.9468852459016394,0.9550430023455825,0.9028219817525992
19.REACTOME_IL_RECEPTOR_SHC_SIGNALING,0.4948220064724919,0.5190730837789661,0.498220640569395,0.5211970074812967,0.42634107285828665,0.42857142857142855
190.PID_ILK_PATHWAY,0.9551848874598071,0.976381273724167,0.9551938919027526,0.976381273724167,0.949516648764769,0.9705627705627705
191.IPA_LEF1_UP,0.8644931227712684,0.3283715391485561,0.8645276292335116,0.32936626004165426,0.3849044785468212,0.28013426914861156
192.IPA_IRF7_UP,0.9250187453136716,0.9453945394539454,0.9248063952035973,0.9455578821417888,0.8869760479041916,0.922562893081761
192.REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.9545113721569608,0.9186918691869187,0.9545340994254309,0.9189350882440921,0.8514221556886228,0.877751572327044
193.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.9812218327491237,0.9859928591046416,0.9812218327491237,0.9859928591046416,0.9878152451119298,0.9903766840802859
194.YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.6064891846921797,0.026198439241917504,0.6070686070686071,0.026740947075208913,-0.04562236286919831,-0.03289977046671767
195.BIOCARTA_GATA3_PATHWAY,0.9932401982875169,0.2554831061055127,0.9932432432432432,0.25680473372781065,0.4737762237762238,0.19337670017740982
196.BIOCARTA_CSK_PATHWAY,0.9276934201012292,0.9688176699870074,0.927797833935018,0.9688446559930766,0.9726156751652503,0.9680804547442063
197.ROSS_AML_WITH_CBFB_MYH11_FUSION,0.7288551662575318,0.814697265625,0.7289761320544278,0.8144984134732731,0.7263769580596261,0.8130939809926082
198.REACTOME_NCAM1_INTERACTIONS,0.9733399160701062,0.9826156726397433,0.9730997038499506,0.982620320855615,0.9509529860228717,0.9842014317452481
199.REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,0.9978094194961665,0.9968354430379747,0.997812613926358,0.9968354430379747,0.9894736842105263,0.9958563535911602
2.SUMI_HNF4A_TARGETS,0.9939962476547842,0.9974337040205303,0.9940007499062617,0.9974348011970928,0.9970526315789474,0.9973273942093541
2.LUCAS_HNF4A_TARGETS_UP,0.9452157598499062,0.9700598802395209,0.9448818897637795,0.9709277469003847,0.9612631578947368,0.9701559020044543
20.REACTOME_MTORC1_MEDIATED_SIGNALLING,0.9979101358411703,0.9937142857142857,0.997911227154047,0.9937142857142857,0.9750838524197413,0.994053064958829
20.BIOCARTA_IGF1MTOR_PATHWAY,0.9508881922675027,0.88,0.9514360313315927,0.8822857142857143,0.8950646861523718,0.9126258005489478
20.PID_MTOR_4PATHWAY,0.6786833855799373,0.74,0.6798955613577023,0.7434285714285714,0.751796837565884,0.7909423604757548
20.BIOCARTA_MTOR_PATHWAY,0.9043887147335423,0.8982857142857142,0.9054830287206266,0.8994285714285715,0.8931480594154289,0.9217749313815188
20.KEGG_MTOR_SIGNALING_PATHWAY,0.6974921630094044,0.7005714285714286,0.7002610966057441,0.7034285714285714,0.6152371825586967,0.7451967063129002
200.PID_KIT_PATHWAY,0.8358143607705779,0.7819879187259747,0.8355205599300087,0.783205268935236,0.7231491136600625,0.7769607843137255
201.REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,0.9938080495356038,0.9428504233301975,0.9938080495356038,0.9433207902163687,0.9510439164866811,0.9242864054184808
202.SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,0.4634517766497462,0.401894451962111,0.46294416243654823,0.401894451962111,0.41904761904761906,0.255718954248366
203.PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,0.6484861498818982,0.7889655172413793,0.6479175611850579,0.7891954022988505,0.6733936441660867,0.7977194982896237
204.REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,0.9950738916256158,0.16634980988593157,0.9950738916256158,0.16730038022813687,-0.25,-0.09781790820165538
204.REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,1.0,0.11074144486692016,1.0,0.1112167300380228,-0.7998417721518988,-0.28969149736644095
204.REACTOME_PTK6_REGULATES_CELL_CYCLE,0.9988632057597575,0.904467680608365,0.9988632057597575,0.9049429657794676,0.8860103626943006,0.8488975356679637
205.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.9685077519379846,0.9673611111111111,0.9685230024213075,0.9673611111111111,0.9525283797729618,0.927710843373494
205.HALLMARK_MYC_TARGETS_V2,0.9898255813953488,0.9951388888888889,0.9898305084745763,0.9951388888888889,0.9917440660474717,0.9891566265060241
205.SCHUHMACHER_MYC_TARGETS_UP,0.9748062015503876,0.9875,0.9753026634382567,0.9868055555555556,0.9721362229102167,0.9710843373493976
205.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.8381782945736435,0.8027777777777778,0.837772397094431,0.8020833333333334,0.7440660474716202,0.6144578313253012
206.IPA_STAT5A_UP,0.946532156368222,0.8415523781733294,0.9465591126796068,0.8423200233168172,0.8043684710351378,0.7933884297520661
206.WIERENGA_STAT5A_TARGETS_DN,0.6489281210592686,0.606653049314269,0.6463322409881522,0.6062372486155639,0.5276986388097499,0.5433119069482706
207.RUIZ_TNC_TARGETS_UP,0.834568491513268,0.868231046931408,0.8324169256514463,0.8674916215519464,0.8530685001273236,0.8695211553078287
208.REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,0.9978016609672692,0.9823350814242341,0.997802734375,0.9826110957769804,0.9904849600982197,0.9640333975594091
208.REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,1.0,0.9914435550648634,1.0,0.9914435550648634,0.9815837937384899,0.9861913937058445
209.REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,0.9934902353530295,0.7825242718446602,0.9934918648310388,0.7830790568654646,0.888126491646778,0.6397849462365591
21.BIOCARTA_RB_PATHWAY,0.9743157894736842,0.9292383292383293,0.9743265993265994,0.9307125307125307,0.9355742296918768,0.9144196951934349
21.BIOCARTA_IL2RB_PATHWAY,0.7629473684210526,0.772972972972973,0.7622053872053872,0.773955773955774,0.742296918767507,0.7198124267291911
21.EGUCHI_CELL_CYCLE_RB1_TARGETS,0.9541052631578948,0.942997542997543,0.9541245791245792,0.942997542997543,0.9518207282913165,0.9232121922626025
211.KAMIKUBO_MYELOID_CEBPA_NETWORK,0.9631417288284335,0.9444444444444444,0.9631901840490797,0.9444791016843419,0.9078549848942599,0.9140308191403081
212.WAKASUGI_HAVE_ZNF143_BINDING_SITES,0.6861069836552749,0.8271719038817006,0.686456400742115,0.8282548476454293,0.7117346938775511,0.8315585672797676
213.GO_LSM1_7_PAT1_COMPLEX,0.9985747372171744,0.9980842911877394,0.9985760056959773,0.998085513720485,0.9843253547977123,0.9975683890577508
214.IPA_MITF_UP,0.979706877113867,0.9852320675105485,0.9797205948625507,0.9852515143534369,0.961310364303869,0.9816776409962783
214.IPA_MITF_DN,0.944532130777903,0.9659810126582279,0.9445696259576386,0.9660258098498815,0.9454956227054504,0.9653592900085886
215.IPA_STAT6_DN,0.9230271668822768,0.9457347514651617,0.9228783478541465,0.9457935819601041,0.8880813953488372,0.9163430991881398
215.GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.6652652005174644,0.5990883438246147,0.6640851887705711,0.5986556808326106,0.49186046511627907,0.3353335686551359
217.IWANAGA_CARCINOGENESIS_BY_KRAS_UP,0.4152851924697949,0.41089108910891087,0.41453831041257366,0.4096854012018381,0.19347037484885127,0.25696316262353996
217.SWEET_KRAS_TARGETS_DN,0.7901095813430739,0.8051626591230552,0.7903452147067078,0.8052315305761754,0.7879887142281338,0.7421383647798742
217.SINGH_KRAS_DEPENDENCY_SIGNATURE,0.9994380443944928,1.0,0.9994386752736458,1.0,0.9995969367190649,1.0
218.IPA_GLI2_UP,0.5084840574305426,0.667935871743487,0.5094093534563071,0.6690042075736325,0.5686356073211315,0.692563356875779
219.RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,0.996142719382835,0.9571390302705599,0.996142719382835,0.9571619812583668,0.9443168771526981,0.9322132097334879
22.KIM_PTEN_TARGETS_DN,1.0,0.9953464322647363,1.0,0.9953488372093023,0.9877121123464014,0.9951278928136419
22.SA_PTEN_PATHWAY,0.9802828975567939,0.9612202688728024,0.9803250641573995,0.9612403100775194,0.9455822118197776,0.9476248477466505
22.BIOCARTA_PTEN_PATHWAY,0.9614230604372053,0.5124095139607032,0.9615055603079555,0.5136950904392765,0.585722644821533,0.3325213154689403
220.BILD_HRAS_ONCOGENIC_SIGNATURE,0.865923113431419,0.8866630076838639,0.864326375711575,0.8850480109739369,0.8592188919164396,0.8547650130548303
221.IPA_BHLHE41_DN,0.9990167158308751,0.988009592326139,0.9990171024179281,0.9880148180431466,0.9593796159527327,0.9834752128192289
222.JOHNSTONE_PARVB_TARGETS_1_DN,0.9185729275970619,0.9303515798842902,0.9183801930339908,0.9296996662958843,0.9226532017443195,0.9206092776367413
223.REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,1.0,1.0,1.0,1.0,0.998914223669924,1.0
224.IPA_AHR_UP,0.5689593727726301,0.516366453612241,0.5689593727726301,0.5164537359659311,0.2769263069494016,0.45589500860585197
225.REACTOME_MISSPLICED_LRP5_MUTANTS_HAVE_ENHANCED_BETA_CATENIN_DEPENDENT_SIGNALING,0.9993943064809206,0.986562150055991,0.9993944898577051,0.9869354236655469,0.981101068200493,0.9833475661827498
226.IPA_MYBL2_DN,0.895910780669145,0.8783505154639175,0.8962857142857142,0.8785175017158545,0.864277544796035,0.8711078928312816
227.GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,0.697719087635054,0.7922242569375968,0.697841726618705,0.7916079977471134,0.6428796471329553,0.7625356364246185
228.GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.6480747451868629,0.7380717341230668,0.6471420486700622,0.7365131578947368,0.5652006172839507,0.6919468334636435
228.GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.6687429218573047,0.7469562356038171,0.66723259762309,0.7470394736842105,0.5910493827160493,0.6982017200938233
229.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,0.9965083798882681,0.9900107991360692,0.9965116279069768,0.9900161899622234,0.9961999415375621,0.9780085522296884
229.REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,0.9983705772811918,0.978671706263499,0.9983720930232558,0.9786832164058283,0.9830458930137387,0.9596823457544288
23.PID_PI3KCI_PATHWAY,0.9303721488595438,0.8624464540694907,0.929656274980016,0.8640038040893961,0.8732394366197183,0.8086774699424987
23.PID_IL2_PI3K_PATHWAY,0.8895558223289316,0.8100904331270823,0.890087929656275,0.81169757489301,0.7965571205007824,0.7569262937794041
230.GO_MON1_CCZ1_COMPLEX,1.0,1.0,1.0,1.0,0.9998743086978381,1.0
231.PID_FOXM1_PATHWAY,0.9434229137199435,0.9625038735667802,0.9437376307605315,0.9625038735667802,0.9175738724727839,0.9613784907902555
232.REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,0.9874680306905371,0.9862668161434978,0.9874680306905371,0.9862668161434978,0.9670515347789355,0.9844357976653697
232.REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,0.9923273657289002,0.7542040358744395,0.9923273657289002,0.7547645739910314,0.7214869050971557,0.7084491384102279
233.BIOCARTA_PITX2_PATHWAY,0.9748647788736876,0.9745111731843575,0.9748807631160572,0.974520069808028,0.9658568614576494,0.9755409219190969
234.IPA_STAT1_UP,0.9112183105819562,0.9444868578907187,0.9105273958547097,0.9439598778892281,0.9017555705604321,0.9386004514672687
234.GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,0.7469978446063841,0.7774021158250627,0.7462548737943772,0.7767117313563018,0.7113436866981769,0.7594808126410835
235.REACTOME_L1CAM_INTERACTIONS,0.7739967143862942,0.9081580297588507,0.7729298615998124,0.9073884043099025,0.812767094017094,0.9121384157880508
236.REACTOME_CHL1_INTERACTIONS,0.9995333644423705,0.9817951959544879,0.9995334732913459,0.9817951959544879,0.9655259184700553,0.9827543114221444
237.HOOI_ST7_TARGETS_DN,0.46370176586003925,0.6076454033771107,0.4622929380993897,0.6070339976553342,0.5140879881364311,0.6075697211155379
237.HOOI_ST7_TARGETS_UP,0.8325703073904512,0.8813320825515948,0.8312990409764603,0.8808909730363423,0.8470093919920909,0.8717629482071713
238.REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.9828728020095913,0.9843021829776797,0.9828767123287672,0.9843021829776797,0.9766200762388818,0.978069069826065
24.KEGG_FOCAL_ADHESION,0.8781666231392008,0.89776716753265,0.8745267006136571,0.8928822125508915,0.8538854671733718,0.8958524139735706
24.GO_CELL_MATRIX_ADHESION,0.8174458083050404,0.836961100968965,0.8153805979892936,0.8339182928541345,0.8000262088848119,0.8310872693968337
24.GO_CELL_SUBSTRATE_ADHESION,0.8822146774614782,0.8831624771801714,0.8802715759237498,0.8802470869015864,0.8592582885598218,0.8711239042260892
240.IPA_TCF12_UP,0.9339498018494056,0.8455992790627817,0.9339846844467916,0.8460384153661464,0.8657187993680885,0.81620029455081
241.REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,0.9986856516976998,0.9969788519637462,0.9986859395532195,0.9969788519637462,0.9955545156761816,0.9967793880837359
242.REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,0.9946737683089214,0.8698207464002351,0.9946766036731435,0.8701908957415565,0.9156479217603912,0.8224495937405959
243.REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,0.9943905070118663,0.6914195155082635,0.9943905070118663,0.6923251075390536,0.705054945054945,0.6975996570938705
244.GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.8514869549352307,0.9070939137444579,0.8504281289852432,0.9065458207452165,0.8897177419354839,0.9199928083423229
245.BIOCARTA_CELLCYCLE_PATHWAY,0.8956158663883089,0.9392080312325711,0.8956594323873122,0.9392080312325711,0.837222870478413,0.9421828908554573
245.MYC_UP.V1_UP,0.5290187891440501,0.833798103736754,0.5217028380634391,0.8310094813162298,0.6050175029171528,0.8395280235988201
246.VERHAAK_GLIOBLASTOMA_PRONEURAL,0.9688566552901023,0.9945265462506842,0.968497232865049,0.9934390377255331,0.9839901477832512,0.9944512946979038
246.VERHAAK_GLIOBLASTOMA_CLASSICAL,0.6911262798634812,0.8631636562671046,0.6777352064708386,0.8594860579551667,0.771551724137931,0.8557336621454994
246.PID_WNT_CANONICAL_PATHWAY,0.8848122866894198,0.8188286808976464,0.8846317581949766,0.8195735374521597,0.8830049261083743,0.7977805178791615
247.YU_MYC_TARGETS_UP,0.9375881523272215,0.966501240694789,0.9373680506685432,0.966501240694789,0.9397477814105558,0.9623883403855195
248.REACTOME_GLUCOSE_METABOLISM,0.631414430841365,0.8074915566472214,0.6285119667013528,0.8062634326066933,0.723931879294891,0.8215158924205379
248.REACTOME_GLYCOLYSIS,0.5464964834592342,0.7476205096714769,0.5426638917793964,0.7466994166410807,0.6522258739169405,0.7545843520782396
248.KEGG_PYRUVATE_METABOLISM,0.8306850742380828,0.9361375498925392,0.8309053069719042,0.9361375498925392,0.8852703913952794,0.9410146699266504
248.KEGG_GLYCOLYSIS_GLUCONEOGENESIS,0.7989059650950768,0.894381332514584,0.7986472424557752,0.894074301504452,0.7851807588885569,0.9028117359413202
249.HSIAO_HOUSEKEEPING_GENES,0.8235294117647058,0.9542102028272895,0.8121937942297224,0.9492931776275353,0.8677430436276193,0.9503042596348884
249.WONG_EMBRYONIC_STEM_CELL_CORE,0.8412309368191722,0.9422249539028887,0.8317909635274905,0.9363859864781807,0.8430092751631741,0.9438810006761326
249.REACTOME_TRANSLATION,0.9547930283224401,0.9904732636754764,0.9512792596624932,0.9895513214505224,0.9749227069735487,0.9895199459093983
249.RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,0.7516339869281046,0.8844499078057775,0.7392487751769189,0.8789182544560541,0.7358296118172449,0.8881000676132522
249.REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.988562091503268,0.9984634296250768,0.9882961350027218,0.9984634296250768,0.9975953280659567,0.9983096686950642
249.SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,0.6473311546840959,0.7842655193607867,0.6309199782253675,0.7741241548862938,0.5754036413603573,0.783975659229209
25.REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,0.9697346600331676,0.8701993193971803,0.9697346600331676,0.8716577540106952,0.7677957781050565,0.856440511307768
25.BIOCARTA_P38MAPK_PATHWAY,0.6844941956882256,0.6869227029654837,0.6865671641791045,0.687894992707827,0.7079037800687286,0.6710914454277286
250.BROWNE_INTERFERON_RESPONSIVE_GENES,0.9866449511400651,0.9937426671881111,0.9866710013003901,0.993747557639703,0.9846846846846847,0.9927272727272727
251.VERHAAK_GLIOBLASTOMA_MESENCHYMAL,0.7148769832145321,0.8820195775373518,0.7097588978185994,0.8771251931993818,0.7747504720798489,0.880718954248366
251.PHILLIPS_GLIOBLASTOMA_MESENCHYMAL,0.8850310416187629,0.9626481195260175,0.8840413318025259,0.9611025244719217,0.929592662530348,0.9629629629629629
251.ANASTASSIOU_MULTICANCER_INVASIVENESS,0.8829616003679006,0.9010819165378671,0.8824339839265213,0.9005667181865018,0.846776369031562,0.8951525054466231
251.SEGERMAN_MULTITHERAPY_RESISTANCE,0.8512301678546792,0.9062339000515198,0.8502870264064294,0.9059763008758372,0.9004585918532506,0.9052287581699346
252.GO_RIBOSOME,0.6531117762410982,0.8674960744051214,0.6400371095763323,0.8585019267822736,0.7084124830393487,0.8792940859490772
252.GO_CYTOKINE_ACTIVITY,0.7293838373413148,0.8687039497523855,0.7283785176785899,0.8688583815028902,0.7412483039348711,0.8838744442947595
252.GO_MATURE_RIBOSOME_ASSEMBLY,0.9262049747135928,0.9567580625679429,0.9260900938047624,0.956888246628131,0.9439620081411126,0.9528492523238583
252.GO_CYTOSOLIC_RIBOSOME,0.8250593456497058,0.9327213431573862,0.8191938975363364,0.9294315992292871,0.8545454545454545,0.938569311599084
252.GO_ENDOTHELIAL_CELL_MATRIX_ADHESION,0.837134895242027,0.9054233603092161,0.8375425213895474,0.9058285163776493,0.7986431478968793,0.9066415196012394
252.GO_REGULATION_OF_CHAPERONE_MEDIATED_PROTEIN_FOLDING,0.9864795128496233,0.9595361758666505,0.9864962375012886,0.9596579961464354,0.9242876526458615,0.9498854910413579
252.GO_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,0.8039013314067499,0.8689455248218384,0.8038346562210081,0.8693400770712909,0.8350067842605156,0.8671696079752121
253.HALLMARK_MYC_TARGETS_V1,0.9041028175976273,0.9725987035945787,0.9009387351778656,0.970839469808542,0.9483244597557157,0.9706546275395034
253.KIM_MYC_AMPLIFICATION_TARGETS_UP,0.759268413247652,0.857100766057749,0.7534584980237155,0.8527245949926362,0.7973692452239274,0.8468236052886166
254.HALLMARK_E2F_TARGETS,0.9190437381146428,0.9530487804878048,0.9160782183595871,0.9515539305301646,0.9093275488069414,0.930411206507004
255.KEGG_ECM_RECEPTOR_INTERACTION,0.6866096866096866,0.8735135135135135,0.6864467125563731,0.8721621621621621,0.7990733967325042,0.894937917860554
255.HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.7264957264957265,0.8867567567567568,0.7232375979112271,0.8835135135135135,0.7339673250426725,0.8994746895893028
256.HALLMARK_E2F_TARGETS,0.9501278772378516,0.9776536312849162,0.9486721144024515,0.9756169212690952,0.9662408759124088,0.9777303233679072
256.PID_E2F_PATHWAY,0.9222506393861892,0.9241399588356366,0.9226251276813074,0.9245005875440658,0.9197080291970803,0.9115314215985357
256.HALLMARK_G2M_CHECKPOINT,0.928388746803069,0.9597177300793884,0.9264555669050051,0.9579905992949471,0.944647201946472,0.9560707748627212
256.REACTOME_CELL_CYCLE,0.8038363171355499,0.8753307850632167,0.7844739530132788,0.8648648648648649,0.8083941605839416,0.8715680292861501
256.REACTOME_CELL_CYCLE_MITOTIC,0.7974424552429668,0.866215818876801,0.7826864147088867,0.854876615746181,0.7986618004866181,0.8611958511287371
257.HALLMARK_INTERFERON_ALPHA_RESPONSE,0.9304878048780488,0.961939284096058,0.9299065420560748,0.9603534209333937,0.9360412926391383,0.9610711071107111
257.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.890650406504065,0.9288627095604893,0.8856156034132466,0.9252378794743996,0.8936265709156194,0.9248424842484249
258.MOSERLE_IFNA_RESPONSE,0.8578961244397575,0.9290093578573734,0.8580458256518304,0.9280413036463375,0.8906081324217344,0.9218045112781955
258.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.8186132349064066,0.8977089383672152,0.8182775875691335,0.8964181994191674,0.8463476070528967,0.8913533834586466
259.GSE14308_TH17_VS_NATURAL_TREG_DN,0.7110292828335963,0.8353317346123101,0.7064380685794261,0.8331004192453584,0.6755665245680952,0.828745487364621
26.BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,0.9951790633608816,0.9984258166076347,0.9951840385276918,0.9984261263033641,0.9974639094810769,0.9987513007284079
26.GO_EPITHELIAL_CELL_DIFFERENTIATION,0.6701101928374655,0.7843368752459662,0.6474028207774338,0.7694275034428487,0.7255169722980882,0.7671175858480749
260.HALLMARK_SPERMATOGENESIS,0.6958904109589041,0.6611203549639489,0.6955223880597015,0.658624514697726,0.5223920622150711,0.6805629314922995
260.HALLMARK_MTORC1_SIGNALING,0.8443337484433375,0.903771491957848,0.8422885572139304,0.8993344425956739,0.8860284258514347,0.9118428040361126
260.HALLMARK_G2M_CHECKPOINT,0.9559153175591532,0.9633943427620633,0.954726368159204,0.9611758180809762,0.9600429069455618,0.9607010090281466
261.HALLMARK_XENOBIOTIC_METABOLISM,0.49417989417989416,0.6200274348422496,0.48518831993228945,0.6145404663923183,0.49988165680473373,0.6002848326608118
261.HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.8747089947089947,0.948559670781893,0.8702920016927634,0.9453589391860997,0.8932544378698225,0.9430334678376454
261.HALLMARK_COAGULATION,0.5197883597883598,0.7688614540466392,0.5137537029200169,0.7652034750800183,0.5997633136094674,0.7704723474958461
262.HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.8310353472048132,0.9336456439658789,0.823831600050119,0.9296099538655109,0.8624898889624237,0.9337358161187082
262.GO_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.7865379794434696,0.9086141798349882,0.7854905400325773,0.9077310219488327,0.8124126774027502,0.9124236252545825
262.CORDENONSI_YAP_CONSERVED_SIGNATURE,0.8801704687891703,0.9268633757516431,0.8791504823956897,0.9258353138543268,0.8919038164570924,0.9258801280186209
262.SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.8825520180496365,0.9483988253391135,0.8780228041598798,0.9451978190968824,0.9128612397970439,0.9480651731160896
263.VERHAAK_GLIOBLASTOMA_MESENCHYMAL,0.5776815776815777,0.8304789550072569,0.5623348546721114,0.8215839860748477,0.7644618575708688,0.8888635326335007
263.LIM_MAMMARY_LUMINAL_PROGENITOR_UP,0.6488696488696488,0.7956458635703919,0.6471294739370647,0.793733681462141,0.8200046093569947,0.8605659516202647
263.JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.5913900913900914,0.8522496371552976,0.5865962046601009,0.8500145053669858,0.7828992855496658,0.9032405294386125
264.HALLMARK_INTERFERON_ALPHA_RESPONSE,0.8173110414489725,0.9329059829059829,0.8154648132059079,0.9316823228010248,0.8754448398576512,0.932825484764543
264.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.7490421455938697,0.8111111111111111,0.7442224152910513,0.8057216054654142,0.7831405693950177,0.7936288088642659
264.HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.7265761058864507,0.8346153846153846,0.7275412684622068,0.8353970964987191,0.7866992882562278,0.8291782086795937
264.HALLMARK_APOPTOSIS,0.5489376523859283,0.611965811965812,0.5452649869678541,0.609735269000854,0.6483540925266904,0.5978762696214219
264.GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,0.8916753744339951,0.955982905982906,0.8886185925282363,0.9521776259607173,0.9314946619217082,0.9529085872576177
264.GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,0.9019505398815744,0.9487179487179487,0.8978279756733275,0.946199829205807,0.9388345195729537,0.9478301015697138
264.GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,0.70445837687217,0.852991452991453,0.6990443092962642,0.8501280956447481,0.7915925266903915,0.8492613111726686
265.BIDUS_METASTASIS_UP,0.7964525200086524,0.9144090146247902,0.7902702702702703,0.9108341323106424,0.8427249789739276,0.9015544041450777
265.CRC_proliferation_signature,0.8031581224313217,0.8863581874850156,0.7978378378378378,0.8794343240651965,0.8533781889543033,0.8678756476683938
266.GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,0.8720242389265618,0.8725137039937353,0.8695025234318673,0.8715740015661707,0.8646372099896557,0.8802129547471162
267.HALLMARK_MTORC1_SIGNALING,0.70792736935341,0.8728750923872876,0.7039167957512724,0.8689332347868933,0.7877830437072143,0.8658247829518547
268.KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,0.9488866396761133,0.951974992895709,0.9481668773704172,0.952002272081795,0.919220945083014,0.9412719013627514
268.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.8044028340080972,0.8797953964194374,0.8005056890012642,0.8770235728486225,0.8122605363984674,0.8617780661907852
268.HALLMARK_INTERFERON_ALPHA_RESPONSE,0.9271255060728745,0.9428815004262575,0.9261694058154235,0.9420619142289123,0.9029374201787995,0.9315379623621025
27.REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,0.9962370649106302,0.986096256684492,0.9962370649106302,0.9866310160427807,0.9667689161554193,0.9871794871794872
27.CHANG_CYCLING_GENES,0.967074317968015,0.953475935828877,0.9661335841956726,0.9518716577540107,0.9524539877300614,0.9476923076923077
27.REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,0.8889934148635936,0.9187165775401069,0.8894637817497648,0.9208556149732621,0.918200408997955,0.9256410256410257
28.PID_TCR_JNK_PATHWAY,0.9832214765100671,0.9541870071348104,0.9832383506537044,0.9545625234697709,0.9717020391177694,0.9274924471299094
28.HAN_JNK_SINGALING_UP,0.8322147651006712,0.801351858805858,0.833389205497821,0.8021028914757792,0.7906783187682064,0.7647820457488131
28.REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,0.938255033557047,0.8926023282012767,0.9383171304056319,0.8929778445362373,0.9363295880149812,0.8765645230902028
29.BIOCARTA_GATA3_PATHWAY,0.9908466819221968,0.4372707263389582,0.9908466819221968,0.43800440205429203,0.6024016010673783,0.4248322147651007
3.NFE2L2.V2,0.9740948813982522,0.9579918032786885,0.972568578553616,0.9549180327868853,0.8899049012435991,0.9386526157320286
3.SINGH_NFE2L2_TARGETS,1.0,1.0,1.0,1.0,1.0,1.0
30.BAKKER_FOXO3_TARGETS_UP,0.4119928400954654,0.4731078904991948,0.41562313655336913,0.4748873148744366,0.44608010955152344,0.4528428093645485
31.PID_FOXM1_PATHWAY,0.9252199413489736,0.8909691629955947,0.9258174719375305,0.8932893289328933,0.9011099899091827,0.8836978131212724
32.REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,0.7534284914637559,0.8278639618138425,0.7552447552447552,0.8294573643410853,0.747096399535424,0.8474178403755869
32.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,0.9468233977050098,0.9570405727923628,0.946013986013986,0.9570661896243292,0.9239256678281068,0.9580399061032864
32.REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,0.9916036943744753,0.9812052505966588,0.9916083916083916,0.9818127608825283,0.9668989547038328,0.977112676056338
32.BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.7794570389028828,0.8004176610978521,0.7795804195804196,0.8023255813953488,0.8443670150987224,0.818075117370892
32.REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.9633361321018752,0.926909307875895,0.9633566433566434,0.9269528920691711,0.9096980255516841,0.9257629107981221
33.YANG_BREAST_CANCER_ESR1_UP,0.9970660146699266,0.9976757699012202,0.9970688812896922,0.9976784677887406,0.9940789473684211,0.9958988380041012
34.BIOCARTA_CASPASE_PATHWAY,0.9827188940092166,0.9413399197283112,0.9827238698531529,0.9410493827160494,0.9131064446053584,0.907991202346041
34.SA_CASPASE_CASCADE,0.9902073732718893,0.8956468045693116,0.9902101929167867,0.8959876543209877,0.887762490948588,0.8486070381231672
34.PID_CASPASE_PATHWAY,0.8522465437788018,0.7959246681074406,0.8525770227469047,0.7956790123456791,0.7418537291817524,0.7287390029325513
34.REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10,0.9976958525345622,0.9959864155603582,0.9976965159804204,0.9959876543209877,0.9934829833454019,0.9915689149560117
34.REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,0.9893433179723502,0.8937943809817845,0.9893463864094443,0.8938271604938272,0.8580738595220855,0.8497067448680352
35.HALLMARK_MYC_TARGETS_V2,0.9917389508467576,0.9980591945657448,0.9917457697069748,0.9980591945657448,0.995625,0.9974076474400518
35.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.9591078066914498,0.9742843279961184,0.9587288485348742,0.9742843279961184,0.963125,0.9598185353208036
35.SCHUHMACHER_MYC_TARGETS_UP,0.9710863279636514,0.9868995633187773,0.9711101939744119,0.9868995633187773,0.969375,0.9825016202203499
35.MYC_UP.V1_UP,0.8979760429574556,0.9456574478408539,0.8935204292199752,0.9446870451237264,0.89125,0.9274141283214518
35.PID_MYC_ACTIV_PATHWAY,0.8822800495662949,0.928190198932557,0.8832026413536938,0.928190198932557,0.809375,0.9034348671419313
35.HALLMARK_MYC_TARGETS_V1,0.952912019826518,0.977680737506065,0.9513000412711514,0.9771955361475012,0.95,0.9708360337005832
35.DANG_BOUND_BY_MYC,0.32135481206113176,0.4949053857350801,0.2789929839042509,0.462882096069869,0.258125,0.3408943616331821
35.SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.8661710037174721,0.9165453663270258,0.8638052001650846,0.9165453663270258,0.856875,0.8937135450421257
35.BENPORATH_MYC_MAX_TARGETS,0.33044196612969845,0.47307132459970885,0.304581097812629,0.4531780688985929,0.268125,0.3123784834737524
35.ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.9099545642296571,0.9267345948568656,0.909203466776723,0.9262493934983018,0.885625,0.8950097213220998
36.SEIDEN_ONCOGENESIS_BY_MET,0.15529117094552286,0.15491056361795477,0.155819774718398,0.1552480593992575,0.15582506431459023,0.06574004507888806
37.REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK,1.0,1.0,1.0,1.0,0.9990278677900194,1.0
37.REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1,0.9993272788429196,0.9927719551861222,0.9993279569892473,0.9927797833935018,0.9857420609202852,0.9812382739212008
37.REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,0.9989909182643795,0.9855439103722443,0.998991935483871,0.9855595667870036,0.9734283862605314,0.9771732332707942
37.REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE,0.9983181971072991,0.9725334297072642,0.9983198924731183,0.9732851985559566,0.9543097861309138,0.964665415884928
38.GO_TRANSLATION_INITIATION_FACTOR_ACTIVITY,0.8681574656417423,0.896053362979433,0.8679860302677532,0.8957754307948861,0.8364372469635628,0.8994652406417112
38.GO_REGULATORY_REGION_NUCLEIC_ACID_BINDING,0.12252504076403448,0.4127292940522512,0.10360884749708964,0.39299610894941633,0.21376518218623483,0.4622994652406417
38.GO_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,0.5348241323084091,0.5772651473040578,0.5385331781140862,0.5806003335186215,0.4529014844804318,0.611764705882353
38.GO_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,0.9864896342883764,0.9922178988326849,0.9864959254947614,0.9922178988326849,0.9840755735492578,0.9925133689839573
38.GO_TRANSLATIONAL_INITIATION,0.9934777544840437,0.9936075597554197,0.9932479627473807,0.9927737632017788,0.9854251012145749,0.991711229946524
38.REACTOME_TRANSLATION,0.9932448171441882,0.9877709838799333,0.9927823050058208,0.9872151195108394,0.9819163292847504,0.9834224598930481
38.GO_TRANSLATION_REGULATOR_ACTIVITY,0.8290239925460051,0.7618121178432462,0.830267753201397,0.7648693718732629,0.6968960863697706,0.7687165775401069
38.GO_REGULATION_OF_TRANSLATIONAL_INITIATION,0.7756813417190775,0.7851584213451918,0.7760186263096625,0.7862701500833796,0.7465587044534413,0.7831550802139038
39.NELSON_RESPONSE_TO_ANDROGEN_UP,0.8997440273037542,0.944,0.8994032395566922,0.9440279860069966,0.9167045971779699,0.9482758620689655
39.HALLMARK_ANDROGEN_RESPONSE,0.6979522184300341,0.752,0.6956521739130435,0.7521239380309845,0.7259899863450159,0.7537577365163572
39.DOANE_RESPONSE_TO_ANDROGEN_UP,0.6949658703071673,0.813,0.6901108269394715,0.8105947026486756,0.6868456986800182,0.8333333333333334
4.REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,1.0,0.9710793082886107,1.0,0.9716840536512668,0.9757660167130919,0.9582532271354024
4.REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,0.9988888888888889,0.9215861657722123,0.9988888888888889,0.9228017883755588,0.9328690807799442,0.8923372699807746
40.PID_ATM_PATHWAY,0.9152901313002965,0.9453391898487067,0.9144430326132994,0.9453658536585365,0.9377572016460906,0.9458103361766181
41.EGFR_UP.V1_UP,0.954248366013072,0.9659863945578231,0.954248366013072,0.9659863945578231,0.9664429530201343,0.9724137931034482
42.HALLMARK_ANGIOGENESIS,0.9188485462172719,0.9631425800193987,0.9185827910339841,0.9631485372555358,0.9436596583442839,0.96830583238033
42.LU_TUMOR_ANGIOGENESIS_UP,0.9333140460002893,0.9406724862592952,0.9331887201735358,0.9406820753192178,0.9553219448094612,0.9403692207155694
42.GO_ANGIOGENESIS,0.311586865326197,0.6121888134497252,0.3035430224150398,0.6027153709390658,0.4080157687253614,0.623917660512988
43.BIOCARTA_TGFB_PATHWAY,0.9728074107276259,0.9782608695652174,0.9726947179946285,0.9780893952673094,0.9859726836471022,0.9772226304188097
43.GO_REGULATION_OF_STEM_CELL_PROLIFERATION,0.7712535484834903,0.8523842917251052,0.768725753506416,0.8497808939526731,0.8320413436692506,0.8539676708302718
43.REACTOME_SIGNALING_BY_NODAL,0.7628865979381443,0.6777699859747546,0.7633542226201134,0.6794040315512708,0.804171280915467,0.6605437178545187
44.REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,0.6506361323155216,0.8514792899408284,0.6386063072227874,0.8406268480189237,0.7662043589017832,0.8748955140707718
44.PID_A6B1_A6B4_INTEGRIN_PATHWAY,0.8147582697201018,0.8733727810650888,0.8145981688708036,0.8731519810762862,0.7480894424002265,0.8888269713011981
44.NABA_CORE_MATRISOME,0.8035623409669211,0.9062130177514793,0.7960325534079349,0.9012418687167356,0.8850834984432494,0.9228197269434383
44.KEGG_ECM_RECEPTOR_INTERACTION,0.8679389312977099,0.9582840236686391,0.8646998982706002,0.9577173270254288,0.9295216529861308,0.9662858735023684
45.GO_PHAGOSOME_MATURATION,0.9624378109452736,0.9906377998829725,0.9624564893088016,0.9903452311293154,0.9889485317335017,0.9907550077041603
45.GO_PHAGOSOME_ACIDIFICATION,0.9529850746268657,0.983908718548859,0.9530084535057185,0.9836161497952018,0.9820018945374172,0.9845916795069337
46.BOQUEST_STEM_CELL_UP,0.5142782289756354,0.734624145785877,0.5019638648860958,0.7284372331340735,0.5186931626810374,0.6949267960503915
46.SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,0.7110296044013623,0.8539293849658315,0.700445142707515,0.843438656419015,0.5591108117211182,0.8406537282941777
46.LIM_MAMMARY_STEM_CELL_UP,0.5444066020434897,0.8234624145785877,0.5208169677926159,0.8078565328778822,0.6113169417312226,0.797752808988764
47.ALK_DN.V1_UP,0.6481481481481481,0.7329192546583851,0.654320987654321,0.7329192546583851,0.6463414634146342,0.7423312883435583
48.GO_SKELETAL_SYSTEM_DEVELOPMENT,0.7039458850056369,0.7938271604938272,0.6872465074357819,0.7758024691358024,0.6957658128593832,0.7810143042912874
49.HALLMARK_MYC_TARGETS_V1,0.7423376623376623,0.8555352798053528,0.7367601246105919,0.8522796352583587,0.7468265162200282,0.850104821802935
49.HALLMARK_MYC_TARGETS_V2,0.922077922077922,0.9653284671532847,0.921858774662513,0.9650455927051672,0.9340620592383639,0.9636617749825297
49.WONG_EMBRYONIC_STEM_CELL_CORE,0.74,0.8561435523114356,0.7297507788161994,0.8498480243161094,0.6928772919605077,0.8522012578616353
5.PID_ALK2_PATHWAY,0.9924023154848046,0.9975409836065574,0.9924105529454282,0.9975440032746623,0.9959477712742009,0.9972590223846505
5.TESAR_ALK_TARGETS_EPISC_4D_UP,0.998191027496382,0.9868852459016394,0.9981929887965305,0.986901350798199,0.9657811796488068,0.9826404751027866
5.TESAR_ALK_TARGETS_EPISC_3D_UP,0.9880607814761215,0.9532786885245902,0.9880737260571015,0.9549733933688088,0.8442143178748311,0.9474645957058018
50.HALLMARK_CHOLESTEROL_HOMEOSTASIS,1.0,0.7727272727272727,1.0,0.7727272727272727,0.875,0.7727272727272727
50.HALLMARK_INTERFERON_GAMMA_RESPONSE,0.6666666666666666,0.6818181818181818,0.6774193548387096,0.6818181818181818,0.7083333333333334,0.6818181818181818
50.HALLMARK_INTERFERON_ALPHA_RESPONSE,0.8,0.8181818181818182,0.8064516129032258,0.8181818181818182,0.7916666666666666,0.8181818181818182
51.FEVR_CTNNB1_TARGETS_DN,0.6684743311641359,0.7832229580573952,0.6504153123871433,0.7695364238410596,0.661613909942042,0.7919200695047784
51.HUPER_BREAST_BASAL_VS_LUMINAL_UP,0.8441793203181489,0.7222958057395144,0.8425424340917299,0.7218543046357616,0.7570218457423094,0.7041702867072112
51.BENPORATH_ES_1,0.6988430947216197,0.7059602649006622,0.6879739978331527,0.695364238410596,0.6107891217119928,0.7072111207645526
51.SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,0.7805495300072307,0.8573951434878587,0.7688696280245576,0.8467991169977925,0.7810967454302273,0.8575152041702867
51.NADERI_BREAST_CANCER_PROGNOSIS_UP,0.8839479392624728,0.8653421633554084,0.8837125315998555,0.8653421633554084,0.8845296477931341,0.8588184187662902
52.NRAS_EXTINCTION_DOWN,0.749738584872778,0.784394250513347,0.7491301322199025,0.7839835728952772,0.6742354031510658,0.7420460107684778
52.NEBEN_AML_WITH_FLT3_OR_NRAS_DN,0.8515162077378877,0.8841889117043121,0.8517745302713987,0.8862422997946612,0.866079703429101,0.869309838472834
53.REACTOME_CELL_CYCLE,0.8834264432029795,0.915327833260964,0.8776041666666666,0.9062092922275293,0.8636363636363636,0.8876212207644039
53.PID_E2F_PATHWAY,0.753072625698324,0.7781155015197568,0.7537202380952381,0.7772470690403821,0.7186147186147186,0.710781517398745
53.REACTOME_DNA_REPLICATION,0.9243947858472998,0.9496309161962657,0.9200148809523809,0.9478940512375162,0.9161255411255411,0.9361095265259555
54.GO_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.9724050632911393,0.9969558599695586,0.9722011624968411,0.996956786366403,0.9884753901560625,0.9980993110002376
54.DIERICK_SEROTONIN_FUNCTION_GENES,1.0,0.9990867579908675,1.0,0.9990870359099209,0.9990396158463385,0.997624138750297
54.REACTOME_SEROTONIN_RECEPTORS,0.9863291139240506,0.9972602739726028,0.9863532979529946,0.9972611077297626,0.9891956782713085,0.9978617248752673
54.GO_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.7688607594936708,0.923896499238965,0.7116502400808693,0.8925745587340231,0.8645858343337335,0.9482062247564742
55.ERBB2_UP.V1_UP,0.7701782820097245,0.8717391304347826,0.7614262560777958,0.8670289855072464,0.8185314685314685,0.8826177285318559
55.SMID_BREAST_CANCER_ERBB2_UP,0.9792544570502432,0.994927536231884,0.9786061588330632,0.993840579710145,0.990909090909091,0.9951523545706371
55.MEK_UP.V1_UP,0.6589951377633712,0.8126811594202898,0.653484602917342,0.8083333333333333,0.7451048951048951,0.8306786703601108
55.LIM_MAMMARY_LUMINAL_MATURE_UP,0.9380875202593193,0.9807971014492753,0.9367909238249594,0.9804347826086957,0.9643356643356643,0.9826869806094183
56.BAKER_HEMATOPOESIS_STAT1_TARGETS,0.9843599615014437,0.9624078624078624,0.9843637238393071,0.9636363636363636,0.9435934840748845,0.9587704318126372
57.INGA_TP53_TARGETS,0.985168426344897,0.9901880621422731,0.985168426344897,0.9901880621422731,0.98422037978069,0.9896386822529224
57.KIM_HYPOXIA,0.924333836098542,0.976560370673208,0.924333836098542,0.976560370673208,0.9499866274404921,0.9774176408076515
57.LEONARD_HYPOXIA,0.9396681749622926,0.9670209866448624,0.9384112619406737,0.9664758789860998,0.9483819202995454,0.9665249734325186
58.REACTOME_PI3K_AKT_ACTIVATION,0.868199481865285,0.9239446870451238,0.8684125444552214,0.9239723535831211,0.8955974842767296,0.9539622641509434
58.BIOCARTA_GSK3_PATHWAY,0.7691062176165803,0.863901018922853,0.7694794697704495,0.8646780647508184,0.8558490566037736,0.9154716981132075
59.HALLMARK_E2F_TARGETS,0.7714285714285715,0.6774193548387096,0.7428571428571429,0.6774193548387096,0.7096774193548387,0.6666666666666666
59.HALLMARK_MYC_TARGETS_V1,1.0,0.967741935483871,1.0,0.967741935483871,0.967741935483871,0.9666666666666667
60.HALLMARK_E2F_TARGETS,0.9649661954517517,0.9761474521142031,0.9625192012288787,0.9743774810537712,0.9553158705701078,0.9761078998073218
60.HALLMARK_G2M_CHECKPOINT,0.9096496619545175,0.9212143115287315,0.906605222734255,0.9180801154817755,0.8628659476117103,0.910597302504817
60.HALLMARK_MYC_TARGETS_V1,0.8389674247080516,0.932779183230936,0.832258064516129,0.9303500541320823,0.8832819722650231,0.935645472061657
60.HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.7105101413644745,0.8182146729309722,0.706605222734255,0.8134247564056297,0.7596302003081664,0.8211946050096339
60.HALLMARK_MYC_TARGETS_V2,0.8595574677320221,0.9118178532706903,0.8602150537634409,0.9123060267051606,0.8328197226502311,0.9078998073217727
60.HALLMARK_DNA_REPAIR,0.5952673632452367,0.6920852909288038,0.5929339477726574,0.6903644893540238,0.5781972265023112,0.6847784200385356
61.REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,0.7094560244026437,0.8189902467010901,0.7055386178861789,0.8166953528399311,0.7872579287117597,0.8228060368921185
61.NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,0.7600406710726996,0.8049340218014917,0.759400406504065,0.8043602983362019,0.7502104967723828,0.8093907210732253
61.KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.8146924250127097,0.904188181296615,0.8130081300813008,0.9036144578313253,0.8717373000280663,0.9097261039686976
61.SEKI_INFLAMMATORY_RESPONSE_LPS_UP,0.8599389933909507,0.9282845668387837,0.8584857723577236,0.9274239816408492,0.9014875105248387,0.9346003353828954
62.HALLMARK_ANDROGEN_RESPONSE,0.998524106264349,0.9996023856858847,0.9985257985257985,0.9994038155802861,0.9990279465370595,0.9989206691851052
62.NELSON_RESPONSE_TO_ANDROGEN_UP,0.9981961298786487,0.9992047713717693,0.9981981981981982,0.9992050874403816,0.9992709599027947,0.9994603345925526
62.DOANE_RESPONSE_TO_ANDROGEN_UP,0.9107904230895375,0.9411530815109344,0.906961506961507,0.9383942766295708,0.9120291616038882,0.9155423637344846
62.WANG_RESPONSE_TO_ANDROGEN_UP,0.9996720236142997,0.9998011928429423,0.9996723996723996,0.9998012718600954,0.9995139732685298,0.999190501888829
63.KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.9820027688047993,0.9819078947368421,0.9824884792626728,0.9819078947368421,0.9537190082644628,0.979676915059927
63.KEGG_PYRIMIDINE_METABOLISM,0.7429626211352099,0.8009868421052632,0.740552995391705,0.8037280701754386,0.7652892561983471,0.8191766545075561
64.MAMMOSPHERES,0.9832402234636871,0.9968871595330739,0.9829089640739449,0.9968883702839362,0.9925527513446422,0.9966818747407714
65.ROS_GENES,0.9200180750112968,0.8605985037406484,0.9200542005420054,0.8606332585390177,0.8135265700483092,0.8251106894370651
66.GO_T_CELL_DIFFERENTIATION,0.7724752690509838,0.8383524141363863,0.7636126507988262,0.8281483325037332,0.7652173913043478,0.8499350112253338
66.GO_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,0.6444178715077726,0.7824788451966153,0.6392783393109445,0.7796167247386759,0.7425848719475878,0.8115325534680373
66.GO_LEUKOCYTE_CELL_CELL_ADHESION,0.7438852049135776,0.8633648581383773,0.7286164547331812,0.8494275759084121,0.7889219773674806,0.8773484579936193
66.GO_ADAPTIVE_IMMUNE_RESPONSE,0.7873681921948038,0.8749377799900449,0.7728507770894468,0.8603782976605276,0.8,0.8853834337705305
66.GO_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.7900858788998805,0.9130164260826281,0.7867623084447343,0.9094076655052264,0.8290649195949971,0.9233132458938911
66.GO_DEFENSE_RESPONSE_TO_BACTERIUM,0.7111642569844548,0.8129666500746641,0.7039452233452885,0.8069935291189647,0.7542584871947587,0.8351648351648352
66.GO_INFLAMMATORY_RESPONSE,0.6520273942819872,0.8074912891986062,0.6185197261167265,0.7801144848183176,0.7307921381774866,0.8306747016424436
67.REACTOME_DNA_REPLICATION,0.8091299019607843,0.9249418797741614,0.8026315789473685,0.9179674526735304,0.8841698841698842,0.9496935648621042
67.KEGG_DNA_REPLICATION,0.9718137254901961,0.9940219196280305,0.9715422276621787,0.9940219196280305,0.984041184041184,0.9961695607763024
68.REACTOME_TRANSCRIPTION,0.8949511400651465,0.9369321218599679,0.8933658933658933,0.9337252805986104,0.7899505766062603,0.9087779690189329
68.REACTOME_TRANSLATION,0.8786644951140065,0.9572421165152325,0.8754578754578755,0.9551042223409941,0.8896210873146623,0.9363166953528399
68.KEGG_DNA_REPLICATION,0.9450325732899023,0.9668626402993051,0.945054945054945,0.9663281667557456,0.9481054365733114,0.9466437177280551
69.PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,0.9647860658841348,0.9768392370572208,0.9648260211800302,0.9768602540834845,0.9668411867364747,0.976017130620985
69.COLLER_MYC_TARGETS_UP,0.812570995834911,0.8256130790190735,0.813161875945537,0.8275862068965517,0.775305410122164,0.8428265524625268
7.KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,0.8847294292068199,0.9373171750940242,0.8844872269529804,0.9373433583959899,0.8837739288969918,0.9269607843137255
7.KEGG_PENTOSE_PHOSPHATE_PATHWAY,0.4017790956263899,0.6030087755954868,0.40503517215845986,0.6044277360066834,0.410665451230629,0.5534313725490196
70.KEGG_GLYCOLYSIS_GLUCONEOGENESIS,0.9594947735191638,0.9657338663620788,0.9586776859504132,0.9645916619074815,0.9393767705382436,0.9635854341736695
70.BIOCARTA_GLYCOLYSIS_PATHWAY,0.9699477351916377,0.9697315819531697,0.9699869508481949,0.9703026841804683,0.9796033994334278,0.9658263305322129
70.REACTOME_GLYCOLYSIS,0.975609756097561,0.9674471730439749,0.9756415832970857,0.9674471730439749,0.9626062322946176,0.9607843137254902
70.MOOTHA_GLYCOLYSIS,0.9908536585365854,0.9942889777270132,0.9908655937364071,0.9937178754997145,0.9745042492917847,0.9927170868347339
71.LEE_BMP2_TARGETS_UP,0.7395246263170792,0.8975506979194101,0.6992168379833578,0.8617329470634711,0.8181337562780862,0.9108164326573063
71.NABA_MATRISOME,0.6535162950257289,0.8504082170134316,0.6013215859030837,0.8169607584935475,0.7367168913560667,0.8679147165886636
71.NABA_MATRISOME_ASSOCIATED,0.5809850526831659,0.7893073479062418,0.5491923641703378,0.7640242296549907,0.6605868358445678,0.8122724908996359
71.NABA_CORE_MATRISOME,0.7723597157559422,0.9354753752962865,0.7630934899657367,0.9270476692125362,0.845096484271742,0.9388975559022361
71.KEGG_LYSOSOME,0.7133055623621661,0.8411904134843298,0.7104747919725893,0.8385567553331578,0.6738038593708697,0.8497139885595424
72.HALLMARK_G2M_CHECKPOINT,0.6470588235294118,0.6428571428571429,0.6470588235294118,0.6428571428571429,0.5833333333333334,0.8947368421052632
73.PENG_RAPAMYCIN_RESPONSE_DN,0.9757494105759515,0.992018244013683,0.9744021556079488,0.9904979095400989,0.9772727272727273,0.9895833333333334
74.GO_ANTIGEN_BINDING,0.8832772166105499,0.9671150971599403,0.8810592459605027,0.9668659691081216,0.9399109792284867,0.96826171875
74.GO_ALPHA_BETA_T_CELL_ACTIVATION,0.8594837261503928,0.9372197309417041,0.8583931777378815,0.9369706028898854,0.9233432245301681,0.94189453125
75.SCHUHMACHER_MYC_TARGETS_UP,0.9649256576439191,0.9911504424778761,0.9649790635706129,0.9902189101071263,0.9838953195772522,0.9894459102902374
75.HALLMARK_MYC_TARGETS_V2,0.9900876858558902,0.999534233814625,0.9901027788351732,0.999534233814625,0.9984901862103673,0.9994722955145119
75.MENSSEN_MYC_TARGETS,0.9271826153259627,0.9790405216581276,0.9272934906737723,0.9795062878435026,0.9511826874685455,0.9799472295514512
75.SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,0.9763629431948151,0.9958081043316255,0.976398934145413,0.9958081043316255,0.9944640161046804,0.995778364116095
76.ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,0.9886702444841979,0.9964061096136568,0.9887106357694593,0.9964125560538116,0.9938366718027735,0.9955323901712584
76.RIGGI_EWING_SARCOMA_PROGENITOR_UP,0.8765652951699463,0.8921832884097035,0.8669043374925728,0.8798206278026905,0.889060092449923,0.8942665673864483
76.STAEGE_EWING_FAMILY_TUMOR,0.998211091234347,1.0,0.9982174688057041,1.0,1.0,1.0
77.KONG_E2F3_TARGETS,0.8251410153102336,0.9377949377949378,0.823268921095008,0.9360789360789361,0.9105319720580333,0.964578376949511
77.REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,0.9967767929089444,0.9995709995709996,0.9967793880837359,0.9995709995709996,0.9997313272434175,0.999735659529474
77.WHITFIELD_CELL_CYCLE_G2,0.8122481869460113,0.9317889317889317,0.8075684380032206,0.9253539253539254,0.8957549704459967,0.9584985461274121
77.REACTOME_GENERIC_TRANSCRIPTION_PATHWAY,0.8126510878323933,0.8991848991848992,0.8003220611916264,0.8923208923208923,0.8729177861364857,0.9418450964842717
78.KEGG_STEROID_BIOSYNTHESIS,0.989517819706499,0.9844606946983546,0.9895324494068388,0.9844606946983546,0.9923298178331735,0.9816955684007708
78.KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,0.9524807826694619,0.9853747714808044,0.9525471039776692,0.9853747714808044,0.9721955896452541,0.98747591522158
78.KEGG_PEROXISOME,0.8099231306778477,0.8976234003656307,0.8094905792044662,0.8948811700182815,0.822627037392138,0.8940269749518305
79.KEGG_LYSOSOME,0.8135223555070883,0.9125925925925926,0.8103260869565218,0.9111769059955589,0.8876790830945559,0.936768149882904
79.KEGG_REGULATION_OF_AUTOPHAGY,0.9683751363140676,0.9296296296296296,0.9684782608695652,0.9296817172464841,0.9163323782234957,0.9414519906323185
79.KEGG_FATTY_ACID_METABOLISM,0.9672846237731734,0.9874074074074074,0.967391304347826,0.9866765358993338,0.9856733524355301,0.990632318501171
79.KEGG_PEROXISOME,0.9002181025081788,0.9614814814814815,0.8967391304347826,0.9600296076980015,0.9478510028653295,0.9689695550351288
79.REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,0.9438386041439476,0.9807407407407407,0.9440217391304347,0.9807549962990377,0.9833810888252149,0.9871194379391101
80.HALLMARK_KRAS_SIGNALING_UP,0.8561151079136691,0.8709677419354839,0.8561151079136691,0.8709677419354839,0.8050847457627118,0.8547008547008547
81.MILI_PSEUDOPODIA_HAPTOTAXIS_UP,0.7848176927674836,0.7887426900584795,0.771667662881052,0.7839416058394161,0.26903553299492383,0.2853333333333333
81.HAMAI_APOPTOSIS_VIA_TRAIL_UP,0.8254632396891811,0.8742690058479532,0.8164973102211596,0.8678832116788321,0.3477157360406091,0.5706666666666667
81.SEIDEN_ONCOGENESIS_BY_MET,0.7860131500298865,0.7960526315789473,0.7842199641362821,0.7963503649635036,0.25380710659898476,0.312
82.BILD_MYC_ONCOGENIC_SIGNATURE,0.8850537284272224,0.8976923076923077,0.8786991869918699,0.8934615384615384,0.9085625726462612,0.8814553990610329
82.SCHUHMACHER_MYC_TARGETS_UP,0.9602735265385868,0.9930769230769231,0.9596747967479675,0.9926923076923077,0.9868268113134444,0.9929577464788732
82.HALLMARK_MYC_TARGETS_V1,0.9029632041680234,0.9676923076923077,0.8998373983739837,0.9657692307692308,0.9376210771018985,0.9702660406885759
82.HALLMARK_MYC_TARGETS_V2,0.9833930315858027,0.9980769230769231,0.9834146341463414,0.9980769230769231,0.9969004261913987,0.9980438184663537
82.COLLER_MYC_TARGETS_UP,0.9280364702051449,0.9823076923076923,0.9284552845528455,0.9823076923076923,0.9744285160790391,0.9827856025039123
83.DANG_REGULATED_BY_MYC_UP,0.8611393692777213,0.8692010309278351,0.8604769152714358,0.8679123711340206,0.8658707865168539,0.8588738417676408
83.KIM_MYC_AMPLIFICATION_TARGETS_UP,0.7416073245167853,0.7822164948453608,0.7376966007102993,0.7802835051546392,0.7303370786516854,0.7583749109052031
84.ZHU_CMV_8_HR_UP,0.9549278846153846,0.9766600920447074,0.9549819927971188,0.9766600920447074,0.950849963045085,0.9739917075009423
84.DER_IFN_ALPHA_RESPONSE_UP,0.9759615384615384,0.9621959237343852,0.9759903961584634,0.9621959237343852,0.9538063562453807,0.947606483226536
84.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.9894831730769231,0.9947403024326101,0.9894957983193278,0.9947403024326101,0.9878048780487805,0.9935921598190728
84.EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.9981971153846154,0.9983563445101906,0.9981992797118847,0.9983563445101906,0.9974131559497413,0.9973614775725593
84.BROWNE_INTERFERON_RESPONSIVE_GENES,0.9936899038461539,0.9930966469428008,0.9933973589435774,0.9930966469428008,0.9892830746489283,0.9875612514134942
85.WNT_SIGNALING,0.8436182445381372,0.9075668328047123,0.8415007656967841,0.9053013140009062,0.8722060252672498,0.9026460309535697
85.YU_MYC_TARGETS_UP,0.9586048294365658,0.9796103307657453,0.9578866768759571,0.9796103307657453,0.978134110787172,0.9785322016974538
85.KEGG_CELL_CYCLE,0.7627443464929091,0.8658812868146806,0.7576569678407351,0.8640688717716357,0.7998056365403304,0.8572141787319022
85.REACTOME_CELL_CYCLE,0.7884246837868916,0.8808337109198007,0.7752679938744257,0.869053013140009,0.8294460641399417,0.8731902146779831
86.REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.9844680300284753,0.9834116671274536,0.9844840961986036,0.9823057782692839,0.9635742743312464,0.9778093883357041
86.ZHANG_INTERFERON_RESPONSE,0.9984468030028475,0.9994470555709152,0.9984484096198604,0.9991705833563727,0.9974388161639157,0.9991465149359886
86.EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.9968936060056951,0.9975117500691181,0.9968968192397207,0.9972352778545757,0.9985771200910644,0.9968705547652916
86.ST_INTERFERON_GAMMA_PATHWAY,0.9552161532487704,0.9941940834946088,0.9552624773726403,0.9941940834946088,0.9846328969834945,0.9951635846372688
87.activated_treg,0.8141112618724559,0.7821705426356589,0.8131495707184817,0.7825413223140496,0.7585164835164835,0.7502063273727648
87.HALLMARK_IL2_STAT5_SIGNALING,0.6682496607869742,0.7098191214470284,0.6597379123361952,0.6993801652892562,0.6678571428571428,0.6839064649243466
87.HALLMARK_G2M_CHECKPOINT,0.7123473541383989,0.837984496124031,0.7051513782196114,0.831353305785124,0.7362637362637363,0.8363136176066025
87.HALLMARK_E2F_TARGETS,0.6492537313432836,0.7912144702842377,0.6348847718029824,0.7799586776859504,0.7337912087912087,0.784869325997249
88.SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,0.9610576923076923,0.972877358490566,0.9611137782045127,0.972877358490566,0.956865127582017,0.9715873996294009
88.KIM_MYC_AMPLIFICATION_TARGETS_UP,0.9211538461538461,0.8903301886792453,0.9183869419107057,0.8891509433962265,0.8353584447144593,0.8746139592340951
88.COLLER_MYC_TARGETS_UP,0.9899038461538462,0.9858490566037735,0.9899183869419107,0.9858490566037735,0.9939246658566221,0.9820877084620135
88.SCHUHMACHER_MYC_TARGETS_UP,0.9846153846153847,0.9899764150943396,0.9836773883821411,0.9899764150943396,0.988456865127582,0.9876466954910439
88.BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,0.9120192307692307,0.9121462264150944,0.9111857897263562,0.9133254716981132,0.9295261239368166,0.9092032118591723
89.KEGG_HOMOLOGOUS_RECOMBINATION,0.8989936090501727,0.9416637901277183,0.8988335411928692,0.9414200672935898,0.9311713537707964,0.94064763173229
89.GO_MITOTIC_NUCLEAR_DIVISION,0.6938220818335414,0.8450983776320331,0.6821949966987015,0.8384091105167802,0.7982433916054388,0.8559893448763839
89.GO_REGULATION_OF_TRANSCRIPTION_INVOLVED_IN_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,0.8654227576581209,0.9161201242664826,0.8647934854376055,0.9159692865153999,0.9092982011654421,0.9199200865728794
9.HINATA_NFKB_TARGETS_FIBROBLAST_UP,0.9398302905631267,0.958219552157291,0.9393160195422988,0.9563080283997816,0.9581533477321814,0.9552117263843648
9.SCHOEN_NFKB_SIGNALING,0.956544098740036,0.984980884762425,0.9568012342504499,0.984980884762425,0.9775917926565875,0.9856134636264929
9.HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.9256878374903574,0.9560349535772802,0.9226022113653896,0.9535772801747678,0.9454643628509719,0.9557546145494028
9.TIAN_TNF_SIGNALING_VIA_NFKB,0.978143481614811,0.9877116329874386,0.978400617125225,0.98798470780994,0.9865010799136069,0.9842562432138979
90.SCHUHMACHER_MYC_TARGETS_UP,0.9845928099779897,0.9915611814345991,0.9835164835164835,0.9911429776465627,0.9898336414048059,0.989843028624192
90.DANG_MYC_TARGETS_UP,0.9427732942039618,0.9691983122362869,0.9417582417582417,0.967946014339941,0.9320702402957486,0.96398891966759
90.CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,0.9897285399853265,0.9970464135021097,0.9893772893772894,0.9970476592155209,0.9972273567467652,0.9967682363804248
91.LSC_ASSOCIATED_GENES,0.9631952017448201,0.9894951852932594,0.9618528610354223,0.9874562427071178,0.9793846153846154,0.9886642156862745
92.GO_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,0.9096774193548387,0.9641865630205442,0.9098067287043665,0.9644740494032751,0.9696243005595524,0.9702660406885759
93.Amino_Acid_Metabolism,0.7271929824561404,0.838810641627543,0.7280701754385965,0.8403755868544601,0.7046718576195773,0.8406440866185453
94.Erythroid_associated_genes,0.9584954604409858,0.9891548242333582,0.9578742709008425,0.9891548242333582,0.9725634725634725,0.9904191616766467
95.AML_TCP_vs_untreated_UP,0.9345056065239552,0.9757884676648614,0.9345723014256619,0.9753008233058899,0.9086003372681282,0.9766970618034447
96.GO_DNA_REPLICATION,0.7327842598947609,0.8688389923329682,0.7230417381360777,0.862168081029291,0.7638419738581289,0.875895336939044
96.GO_DNA_DEPENDENT_DNA_REPLICATION,0.7805994051704416,0.9033406352683461,0.7763293310463122,0.9002189980837668,0.7964458804523424,0.9052770062856308
96.GO_REGULATION_OF_DNA_DEPENDENT_DNA_REPLICATION,0.8462594371997255,0.8849945235487404,0.8449399656946827,0.884889132220093,0.8548979292113379,0.8886127759099547
96.GO_DNA_STRAND_ELONGATION,0.8605582246625486,0.9634446878422782,0.8600343053173242,0.963044073364358,0.9227493023938904,0.9649174097354188
96.GO_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,0.843056508808053,0.9490690032858707,0.842652944539737,0.9488091979195182,0.9064473490967837,0.9524923256833796
97.CORDENONSI_YAP_CONSERVED_SIGNATURE,0.9108469539375929,0.937466737626397,0.910869026986878,0.9369345396487493,0.885125982118667,0.939713436063801
97.HALLMARK_APICAL_JUNCTION,0.6532937097573056,0.8187865886109633,0.6449616241643972,0.815859499733901,0.739366025467353,0.8172479048391457
97.HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,0.7743932639920753,0.9348057477381586,0.7677642980935875,0.9302820649281532,0.8471958818748306,0.9394430927277643
98.FOCAL_ADHESION,0.8548895899053628,0.8539823008849557,0.8549404344779257,0.8539823008849557,0.9072039072039072,0.8581937065794851
98.MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.8794251664914126,0.9340305711987128,0.8770147161878066,0.9308125502815768,0.8827838827838828,0.9297098487944422
99.KEGG_SPLICEOSOME,0.9574868322046651,0.9773131672597865,0.9541353383458646,0.9750889679715302,0.949814126394052,0.9766109785202864
99.KEGG_RNA_DEGRADATION,0.8799849510910459,0.8754448398576512,0.8796992481203008,0.8763345195729537,0.8745353159851301,0.8553699284009546
99.REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE,0.9104589917231001,0.9461743772241993,0.9093984962406015,0.9461743772241993,0.9256505576208178,0.9431980906921241
99.REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT,0.9326561324303988,0.9670818505338078,0.9327067669172933,0.9666370106761566,0.9484200743494424,0.966109785202864
99.REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER,0.9405568096313017,0.9501779359430605,0.9406015037593985,0.9501779359430605,0.9530669144981413,0.9455847255369928
